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ABSTRACT 
Inflammatory cytokines play a significant role in the pathogenesis of obesity-related 
diseases and have been implicated as integral factors in both early and late phases of 
atherosclerosis. Lifestyle modifications such as increasing physical activity and making dietary 
changes to induce weight loss are part of the primary prescription for the treatment of metabolic 
syndrome. Additionally, physical activity has been implicated as a potentially effective regimen 
for the control of inflammation, yet little is known about the anti-inflammatory mechanistic 
alterations induced by physical activity.  
Exercise training causes acute changes in inflammation immediately post exercise, 
evidenced by upregulation of inflammatory cytokines and increased activity of leukocytes. 
Production of inflammatory cytokines leads to increased circulating levels of monocytes and 
macrophages as well as other immune cells. Additionally, chronic changes in inflammation occur 
after recurring bouts of exercise, evidenced by upregulation and production of anti-inflammatory 
cytokines and increased sensitivity of macrophages to stimuli. Previous publications from our 
laboratory have found that whole blood samples from exercise trained individuals possess 
significantly increased sensitivity to lipopolysaccharide (LPS) stimuli, resulting in lower levels 
of interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor necrosis alpha (TNFα). Others have 
also noted the decrease in circulating levels of inflammatory cytokines chronically with exercise 
training.  
The research presented in this dissertation is novel in that it explores the expression of the 
melanocortin receptors (MCR) on the plasma membranes of systemic monocytes, indicating a 
novel role for the MCRs as anti-inflammatory receptors that are regulated by chronic exercise 
training. The melanocortin 1 receptor (MC1R), melanocortin 3 receptor (MC3R), and 
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melanocrotin 5 receptors (MC5R) are expressed on immune cell populations. Several lines of in 
vitro research have shown that activation of the MC3R on cultured macrophages leads to 
upregulation of the anti-inflammatory pathways, suggesting a novel role for MCRs in mediating 
exercise-induced inflammation. Here, I show that 12 weeks of resistance training in a young, 
healthy population decreases both MC1R and MC3R receptor density on systemic monocytes in 
conjunction with decreases in C-reactive protein (CRP). Furthermore, the percentage of 
circulating monocytes expressing MC1R increases whiles those expressing MC3R decreases in 
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CHAPTER 1. GENERAL INTRODUCTION 
1.1 Inflammation and Macrophages 
Inflammation has emerged as a focal point in the development of many diseases, 
including obesity, type 2 diabetes (T2D), metabolic syndrome, and cardiovascular disease 
(CVD), and is recognized as a potential causative agent and side effect of atherosclerosis and 
insulin resistance [1-5]. Inflammation refers to the recruitment and activation of leukocytes, such 
as macrophages to injured areas of the body as well as upregulation and increased secretion of 
pro-inflammatory cytokines, such as interleukin-6 (IL-6), interleukin-1 beta (IL-1β), and tumor 
necrosis factor alpha (TNFα) [1-2]. Recent investigations examining the etiology of 
inflammatory associated diseases show that chronic inflammation, evidenced by activation of 
immune cells such as monocytes and macrophages, can augment the onset of such diseases [1-5]. 
Additionally, pro-inflammatory cytokine serum concentrations, as well as concentrations within 
various tissue microenvironments, are significantly elevated in several disease states [3-4]. 
Studying leukocytes, specifically monocyte and macrophage populations, is essential for 
understanding immune abnormalities associated with chronic inflammatory disease states. 
Monocyte and macrophage populations are key leukocytes responsible for the local 
production of a variety of pro-inflammatory and anti-inflammatory cytokines that play an 
important immunomodulatory role in the body [6-9]. Systemic, circulating monocytes are some 
of the first responders to tissue damage within the body and are large contributors to pro-
inflammatory cytokine production, including IL-6, TNFα, and IL-1β, during times of 
inflammation. Conversely, monocytes and macrophages help alleviate inflammation by secreting 
anti-inflammatory cytokines, such as IL-10 [1-2]. Anti-inflammatory cytokines provide negative 
feedback in both autocrine and paracrine manners by inhibiting further production of pro-
inflammatory cytokines from monocytes as well as other leukocytes. Shifts in macrophage 
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activation from a pro-inflammatory to an anti-inflammatory state may ameliorate the effects of 
chronic inflammation and slow the progression of related diseases.  
1.2 Effects of Exercise on Inflammation 
Exercise training has been used as a successful intervention in changing inflammatory 
profiles in several populations, including populations afflicted with obesity, T2D, and CVD [10-
13]. A large body of evidence supports the role of exercise training in decreasing chronic 
inflammation [13-22]; yet, the mechanisms involved in creating these favorable changes remain 
elusive. The lack of a consensus on the underlying mechanisms responsible for exercise-induced 
decreases in chronic inflammation may be partially due to the high variation in exercise training 
regimens utilized during intervention studies, as studies indicate that modality, intensity, and 
duration may impact changes in inflammatory profiles. The degree of metabolic demand and the 
level of fatigue are major contributors to changes in cytokine production that may be linked to 
complex interactions between hormonal changes, metabolic by-products, motor unit recruitment, 
myofibrillar disruption, and increases in body temperature [23-25]. Several lines of research 
support the theory that metabolic changes in conjunction with muscle damage are responsible for 
exercise-induced inflammation [23-29]. For example, high levels of IL-6 are found in 
conjunction with glycogen depletion [26]. Evidence also shows a positive correlation between 
lactate levels and IL-6 in young male wrestlers [27] as well as between muscle soreness and IL-6 
[24, 28]. Furthermore, recruitment of larger muscle groups during an exercise bout leads to 
larger numbers of circulating leukocytes afterwards [29-30]; and high intensity exercise (≥ 75% 
VO2max) leads to secretion of IL-1 and IL-6 more so than moderate or low intensity exercise 
[29-30]. Other causes of change observed in acute systemic cytokine levels following an exercise 
bout may also be explained by blood redistribution following the exercise bout [31].  While 
strenuous exercise leads to a redistribution of blood flow away from the splanchnic organs and to 
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contracting muscle, less strenuous exercise allows for normal blood flow to the splanchnic, 
including renal blood flow [32]. Additionally, cytokine production with strenuous exercise may 
show a larger systemic increase due to less clearance through urinary output, as previous studies 
show that cytokines are removed in the urine following an exercise bout [33]. Thus, the 
increased circulating time for inflammatory cytokine clearance during strenuous exercise may 
cause the larger downstream adaptation to anti-inflammatory cytokine production.  
In addition to the regulatory processes involved in immune response adaptations to acute 
and chronic exercise, the physiological changes that occur in response to chronic exercise that 
also contribute to changes in the inflammatory profile remain unknown. Exploration of the 
regulatory pathways that may be modified by exercise training is convoluted by differences in 
the length, intensity, duration, and modality of the exercise regimens prescribed. Despite these 
differences, the strength of varying protocols is that an overall consensus still develops in the 
realm of exercise science, as several investigations utilizing differing interventions have noted 
changes in the inflammatory profile in response to exercise training [14-15, 21-23, 25, 28, 34-
39]. Interactions of metabolic demand, fatigue, and muscle damage may also contribute to 
physiological adaptations present after chronic, repeated bouts of resistance training and may be 
the most crucial factor in contributing to changes in inflammatory cytokine production, as 
dramatic physiological changes in muscle have been noted after the first few resistance training 
bouts [40]. It is possible that the effects of chronic exercise training may cause adaptations of the 
immune response to occur due to repeated acute upregulation of pro-inflammatory cytokines that 
may desensitize leukocytes to these cytokines [38]. Conversely, it is my hypothesis that there 
may be no desensitization but rather leukocyte sensitization to pro-inflammatory cytokines in 
response to chronic exercise, leading to a faster or more efficient response of the anti-
inflammatory pathways to stimuli. This action may eventually result in a blunted response, 
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where TNFα and other pro-inflammatory cytokines are acutely depressed after an exercise bout 
in trained individuals compared to untrained individuals. Despite immense variation in exercise 
training protocols, significant advances have been made in recent years towards identifying 
possible regulatory processes involved in chronic inflammation through leukocyte stimulation 
[13, 16, 18-19, 41-42]. Specifically, advances in the study of exercise training’s effects on 
systemic monocytes have largely been made by identifying extracellular receptors that regulate 
pro-inflammatory pathways and secretion of pro-inflammatory cytokines from monocytes [18-
19].   
 Interestingly, there are no studies exploring the possible identification of plasma 
membrane receptors that regulate anti-inflammatory pathways and secretion of anti-
inflammatory cytokines from monocytes as a consequence of resistance exercise training. This 
section will focus on the effects of exercise training on circulating markers of inflammation that 
are known to regulate inflammation. 
1.2.1. Acute Exercise and Inflammation 
Exercise training causes acute changes in inflammation immediately post exercise, 
evidenced by upregulation of inflammatory cytokines and increased activity of monocytes and 
macrophages [1-2]. Specifically, heavy resistance training has been shown to acutely upregulate 
systemic inflammatory cytokines and increase circulating levels of monocytes and other immune 
cells [15, 17, 20-22, 25, 27, 30, 43-46].  
IL-6: IL-6 is a major pro-inflammatory cytokine studied in the area of exercise 
physiology. IL-6 is involved in the signaling cascade activated acutely after exercise training that 
leads to upregulation of other pro-inflammatory cytokines and acute phase proteins, including 
CRP. In addition to recruiting other immune cells to the area of damage, IL-6 and IL-1β are also 
known to regulate the synthesis of CRP [47-49]. Specifically, IL-6 can regulate transcription of 
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CRP by increasing CCAAT/enhancer binding protein beta (C/EBPβ) binding to the C/EBP 
binding site centered at position -53 on the CRP promoter [47, 50].  
CRP: Due to its high correlation with the development of atherosclerosis and CVD, 
measurement of CRP levels have become increasingly popular in establishing risk of myocardial 
infarction and may serve as a more reliable and accurate marker of chronic inflammation than 
pro-inflammatory cytokines [51-58]. Thus, CRP is rising in importance in medical communities 
as a global marker of inflammation that may be as reliable as measuring blood cholesterol high 
density lipoproteins and low density lipoproteins in an effort to determine health status [57].  
1.2.2 Chronic Exercise and Inflammation 
Contrary to the acute manifestations of exercise, chronic, recurring bouts of exercise lead 
to an overall decrease in inflammation, evidenced by decreased recruitment of leukocytes into 
the circulation as well as increased sensitization of macrophages to inflammatory stimuli. Studies 
suggest that after repeated bouts of exercise, neutrophil recruitment to damaged muscle is 
attenuated by 10-45% and inflammatory response receptor presentation is altered [23]. 
Recruitment of leukocytes may be largely dependent on beta adrenergic receptor (β-AR) 
stimulation on circulating leukocytes by catecholamines, as blockade of the β2-AR by 
propanolol ameliorates recruitment of monocytes and lymphocytes acutely post exercise [59-60]. 
Furthermore, catecholamine stimulation decreases whole blood levels of TNFα and IL-1β and 
increases secretion of IL-10 from macrophages [42, 61-62]. Thus, a viable hypothesis of 
exercise-mediated decreases in chronic inflammation may be that the transient increases in 
catecholamine and pro-inflammatory cytokine release seen acutely, leads to activation of 
monocyte plasma receptors and anti-inflammatory pathways effectively dowregulating pro-
inflammatory cytokine production. Indeed, chronic changes in inflammation occur after 
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recurring bouts of exercise, evidenced by increased anti-inflammatory cytokines, such as IL-10, 
in circulation and increased sensitivity of macrophages to stimuli [15]. 
IL-10: IL-10 is considered an anti-inflammatory cytokine due to its ability to inhibit the 
release of the inflammatory cytokines from monocytes and macrophages, including IL-6 [8]. IL-
10 works to decrease inflammation through activation of the JAK-STAT signaling pathway. 
Briefly, IL-10 binds its receptor on the plasma membrane of the monocyte, activating the 
tyrosine kinases, janus kinase 2 (Jak2) and tyrosine kinase 2 (Tyk2). Jak2 and Tyk2 then 
phosphorylate the signal transducers and activators of transcription (STAT1, STAT2, and 
STAT5) and help regulate gene expression. IL-10 acts in an anti-inflammatory manner by 
inhibiting pro-inflammatory responses through inhibition of nuclear factor-kappa B (NF-kB) 
[63]. 
1.3 Melanocortin 1 Receptor and Melanocortin 3 Receptor 
Physical activity is known to create favorable changes in the cytokine profile of 
individuals and is a viable treatment for slowing the progression and preventing the onset of 
associated low-grade inflammatory diseases [10, 13, 15-16, 18, 41]. Although physical activity 
is known to decrease circulating inflammatory cytokine levels, the mechanism behind these 
changes remains unknown. With the recent finding that stimulation of melanocortin 3 receptors 
(MC3R) on immune cells leads to upregulation of anti-inflammatory cytokine production, 
MC3R activation provides a potential mechanism for exercise-induced changes in cytokine 
profiles [41, 64-65]. MCRs are G-protein coupled transmembrane receptors that act through Gs 
(stimulatory G protein) to increase cAMP [66]. There are 5 known melanocortin receptors, 
MC1R through MC5R, whose roles are diverse and global in the body. Thus, while the finding 
that MC3R activation on macrophages upregulates IL-10, two other melanocortin receptors, 
melanocortin 1 receptor (MC1R) and melanocortin 5 receptors (MC5R), are also found on 
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immune cells and the MC1R may support the role of MC3R in its anti-inflammatory effects, 
although MC5R does not appear to play a role in immunomodulation on monocytes [6-7, 66-
68]. This section will focus on specific MCRs and their regulation of the immune response 
within monocyte and macrophage populations. 
1.3.1 Melanocortin 1 Receptor 
MC1R and MC3R have been shown to have redundant immunomodulatory roles within 
macrophage cell lines. MC1R activation by agonist, including pro-opiomelanocortin peptide 
(POMC) cleavage products alpha melanocortin stimulating hormone (α-MSH) or 
adrenocorticotrophic hormone (ACTH), leads to upregulation and secretion of IL-10 [69-70]. 
MC1R is thought to increase anti-inflammatory actions through downregulating cluster of 
differentiation 86 (CD86) expression on monocytes [69], a co-stimulatory protein that leads to 
secretion of cytokines and activation of immune cells. 
1.3.2 Melanocortin 3 Receptor 
Like MC1R, activation of the MC3R by agonist, alpha melanocortin stimulating hormone 
(α-MSH) or adrenocorticotrophic hormone (ACTH), causes secretion of IL-10 [71]. Studies have 
shown that exercise increases levels of ACTH acutely which then acts on the adrenal cortex to 
cause secretion of cortisol, a stress response hormone, but the ACTH response is blunted with 
exercise training [72]. Acute increases in ACTH may have significant implications for the 
present project since it may activate MC1R or MC3R on systemic monocytes, leading to 
secretion of anti-inflammatory cytokines, such as IL-10, that then inhibit IL-6, TNFα, and IL-1β 
secretion [6, 8, 41, 71, 73]. Indeed, activation of the MC3R on macrophages is known to inhibit 
IL-6 and TNFα secretion [8, 71, 73-75].  
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1.3.3 Research Focus 
Overall the goal of this research project is to analyze changes in protein expression and to 
determine how modifications to monocyte function can contribute to chronic inflammation and 
associated disease states, such as CVD, obesity, and T2D. Specifically, I will examine the role of 
resistance training in modulating anti-inflammatory receptors on the plasma membrane of 
systemic monocytes. The work included in this dissertation explores a novel role for the MC1R 
and MC3R in regulating anti-inflammatory processes associated with chronic exercise training. 
The specific aims for the project are as follows. 
Specific Aim 1: Hypothesis: MC1R and MC3R expression and density on plasma membranes 
of circulating monocytes changes in response to chronic, repeated resistance training bouts. 
Objectives: 
A. Determine if MC1R cell surface expression on systemic monocytes changes in 
response to resistance training. 
B. Determine if MC3R cell surface expression on systemic monocytes changes in 
response to resistance training. 
Specific Aim 2: Hypothesis: Resistance training will alter CRP levels in conjunction with 
changes in pro and anti-inflammatory cytokine profiles in college aged individuals.   
 
Objectives: 
A. Determine whether resistance training induces a change in CRP levels.   
B. Determine whether resistance training induces changes in representative systemic 
pro-inflammatory cytokines. 
C. Determine whether resistance training induces changes in a representative systemic 
anti-inflammatory cytokine. 
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Specific Aim 3: Hypothesis: MC1R or MC3R expression correlates to changes in the 
inflammatory profile in college-aged individuals in response to resistance training. 
Objectives: 
A. Correlate resistance-training induced changes in MC1R on immune cells and specific 
monocyte populations in whole blood with changes in markers of inflammation. 
B. Correlate resistance-training induced changes in MC3R on immune cells and specific 
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CHAPTER 2. LITERATURE REVIEW 
2.1 Introduction 
Impaired energy homeostasis leads to obesity, a low grade inflammatory state that 
precedes metabolic syndrome and its associated diseases, such as T2D, CVD, and atherosclerosis 
[76]. Currently, more than half of all U.S. adults are overweight or obese. Metabolic syndrome, 
itself, is generally characterized by dyslipidemia, hypertension, insulin resistance, and obesity 
and was estimated to affect 76 million people in the United States alone in 2007 [77]. Recent 
investigations examining the etiology of obesity-related diseases show that chronic 
inflammation, evidenced by activation of immune cells such as monocytes and macrophages, can 
be a determinant in the onset of obesity [1-5]. In addition, macrophages are responsible for the 
local production of a variety of cytokines, including the inflammatory cytokines IL-1β, IL-6, and 
TNFα as well as anti-inflammatory cytokines, such as IL-10 [6-9]. These cytokines play an 
immunomodulatory role in the development of obesity, and serum levels of IL-6, IL-1β, and 
TNFα, as well as levels within various tissue microenvironments, are significantly elevated in 
metabolic syndrome [3-4]. Physical activity is known to create favorable changes in the 
inflammatory profile of individuals and is a viable treatment for slowing the progression and 
preventing the onset of metabolic syndrome, T2D, CVD, and atherosclerosis [10, 13, 15-16, 18, 
41]. Consequently, lifestyle modifications such as increasing physical activity and making 
dietary changes to induce weight loss constitute the primary prescription for the treatment of 
metabolic syndrome [78]. Even though physical activity has been implicated as a potentially 
effective regimen for the control of inflammation, little is known about the anti-inflammatory 
mechanistic alterations that occur with exercise.  
Physical activity may affect inflammation through changes in cytokine expression in the  
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central nervous system (CNS) as well as in peripheral tissues. Extensive research in the 1990s 
has focused on the role of the CNS in the immune response, yet little attention has been paid to 
how these effects manifest in the peripheral and tissue-specific immune response. Melanocortin 
3 and 4 receptors (MC3R and MC4R, respectively) are G-protein coupled receptors that are 
found in the CNS [79-81], peripheral tissues, and leukocytes [67, 82] and may act in mediating 
the inflammatory response [7-8, 83-84]. Thus, the MCRs may play a crucial role in advancing 
our knowledge of how the CNS communicates with the periphery in affecting inflammation. 
Current research on the MC3R and MC4R focuses on their role in obesity, a disease state 
associated with chronic inflammation [85-87]. More novel research on the MC3R has begun to 
focus on understanding its role in the immune response. The most established model for MCR 
activation is best understood in its regulation in a signaling cascade that controls adiposity and 
satiation within the hypothalamus [85-88]. This model states that MCRs are activated in the 
hypothalamus when leptin, secreted from adipocytes, binds leptin receptors on the pro-
opiomelanocortin (POMC) neurons, causing the activation of POMC neurons and release of the 
POMC polypeptide. Once translated, POMC is then proteolytically cleaved into various peptides, 
including α-, β-, and γ- melanocyte-stimulating hormone (MSH), and adrenocorticotropic 
hormone (ACTH). In the hypothalamus, ACTH, γ-MSH, or α-MSH (cleaved from ACTH) can 
bind to the MCR, acting as an activating agonist [83, 89-90].  
In other independent studies involving the culture of macrophages, studies show that 
activation of the MC3R on macrophages can occur by subjecting the cells to media containing 
either cyclic α-MSH (MT-II) or ACTH1-39. Once activated, there is an increase in IL-10 found 
in the cell-free supernatant from the macrophages [91]. IL-10 is known for its effects as an  
anti-inflammatory cytokine, inhibiting pro-inflammatory cytokine (IL-6, TNFα, and IL-1β)  
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secretion from macrophages [15, 62, 74, 84]. ACTH production, itself, can be induced by IL-1β. 
IL-1β is one of several pro-inflammatory cytokines secreted by macrophages during the acute 
phase inflammatory response. IL-1β is also known to activate corticotrophin-releasing hormone 
(CRH) neurons in the paraventricular nucleus (PVN) located in the hypothalamus [89]. PVN 
neurons project to the hypophyseal portal system and noradrenergic neurons in the brainstem and 
POMC neurons in the hypothalamus. Induction of CRH neurons leads to activation of the POMC 
neurons that secrete α-MSH and ACTH which may lead to increased activation of MC3R in the 
hypothalamus as well as in peripheral systemic macrophages [92]. Thus, with the recent finding 
that immune cells possess MC3Rs and stimulation of the MC3R with agonist leads to 
upregulation of anti-inflammatory cytokine production from macrophages, the MC3R provides a 
potential mechanistic link for exercise-induced changes in cytokine profiles [41, 64-65].  
2.2 Pro-inflammatory and Anti-inflammatory Response 
2.2.1 Inflammation and Macrophages 
 Inflammation involves several physiological responses of the body to tissue/cellular 
damage or infection, may be specific or nonspecific, and may be beneficial or harmful in specific 
situations. The nonspecific inflammatory response is induced by infection or injury, resulting in 
vasodilation and increased blood flow to the injured/infected area, increased infiltration of bodily 
fluids into intracellular spaces, and increased number of leukocytes, such as neutrophils, 
lymphocytes, and monocytes, in the area [93]. Responses are dependent on the presence of 
adhesion molecules and inflammatory mediators, such as prostaglandins, histamine, and 
serotonin [94].  Additionally, pro- and anti-inflammatory cytokines are chemical signals that play 
a role in recruiting leukocytes to the area of injury. Leukocytes are defined as white blood cells 
or derivations of hematopoietic stem cells from the bone marrow and are found in several 
lymphoid tissues as well as the blood and lymph circulation. Leukocytes are broadly classified 
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into two groups; granulocytes, containing granules within the cytoplasm, and agranulocytes, 
without granules in the cytoplasm. Within these classifications, leukocyte populations can be 
subdivided into five different types. Granulocytes include neutrophils, basophils, and 
eosinophils. Agranulocytes include lymphocytes and monocytes. As part of the acute cellular 
response to injury, neutrophils are the first line of defense, followed by lymphocytes and 
monocytes as part of the chronic cellular response when sufficient damage or infection occurs 
[95]. 
As the immune system is extensive in its responses to infection/injury and involves the 
communication and function of various cell types, it is impractical to review all immune 
responses. Thus, the focus of this review will be on monocyte/macrophage responses and 
populations, because they large producers of inflammatory cytokines that are widely studied in 
response to exercise training within the peripheral circulation. Monocytes are the immature form 
of macrophages that exist in the vascular endothelium and, in small fractions, in circulating 
blood. Monocytes make up 10-15% of the circulating leukocyte population and primarily 
function in phagocytosis, antigen presentation, cytokine production, and cytotoxicity [96-98]. 
There are several different factors involving various signaling cascades that induce maturation of 
bone marrow derived monocytes into macrophages upon stimulation, including induction by 
autocrine, paracrine, and endocrine cytokines. Maturation requires several steps; hematopoietic 
stem cell to myeloid stem cell to monoblast to promonocyte to monocyte in the bone marrow and 
then monocyte in the blood vessel [99]. During the various stages of differentiation, monocytes 
express different cell surface proteins with specific receptor or adhesion molecule functions 
[100]. Chemoattractants lead to upregulation of adhesion molecules on the cell surface of 
circulating monocytes and signal through the various cell surface receptors to recruit derived and 
differentiated monocytes to an injured tissue [101]. Adhesion molecules allow the binding of 
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monocytes to endothelial cells for movement of the monocytes into the tissue. In addition, the 
immune response leads to vasodilation, effectively slowing blood flow and monocyte movement 
through the injured/infected area to allow for better recruitment [100]. Thus, monocytes are 
allowed to move through diapedesis into the affected tissue, where they will then differentiate 
into macrophages. Different stages of differentiation and combinations of cell surface protein 
expression help determine the function of the monocyte/macrophage within the immune 
response [100]. For example, monocytes express membrane-bound co-stimulatory molecule 
recetpors, such as CD14 that acts as a receptor in the recognition of gram negative bacteria [102-
103].  Additionally, CD11a, CD25, CD35, CD45RO, and CD45RA are found on the cell surface 
of circulating monocytes [96, 98, 100]. Once monocytes travel to the site of injury, they 
differentiate into activated macrophages that remain viable for varying periods of time, lasting up 
to several months. Macrophages also express several cell surface proteins that are used in their 
identification and classification, separate from those of monocytes. Macrophages are known to 
express CD11a, CD16, and CD45RO [96, 98, 100]. CD14 and CD16, a mediator of 
phagocytosis, are the most widely used markers in the exercise literature for the recognition and 
differentiation between monocyte and macrophage populations [102-103]. Heterogeneous 
populations of macrophages exist within injured/infected tissues and are maintained by continual 
influx from the circulation as well as local proliferation [102]. Fully differentiated macrophages 
create a signaling cascade that induces recruitment of other leukocytes to the site of injury and 
continue to regulate the inflammatory response as well as play a role in angiogenesis [104-105]. 
Chemical signals produced from macrophages include: bioactive lipids (prostaglandins, 
prostacyclins, thromboxans, leukotrienes), glutathione, complement components, clotting 
factors, proteinases (elastase, collagenase, angiotensin convertase, stromelysin), protease 
inhibitors, peptidases, lipases, ribonucleases, heat shock proteins, apolipoprotein E, and 
                                     
15 
cytokines (IL-1, IL-6, IL-8, TNFα, interferon γ (IFNγ), macrophage inflammatory proteins, 
regulatory growth factors) [99]. Due to the secretion of various cytokines and other recruiting 
factors, macrophages are part of the nonspecific cell-mediated immune response. Although they 
may use antibody receptors such as CD receptors to recognize pathogens, macrophages are not 
considered part of the humoral immune response, as they do not secrete antibodies in response to 
antigens in order to neutralize the antigen [106]. 
2.2.2 Cytokines: IL-6 and IL-10 
Pro- and anti-inflammatory cytokines help maintain inflammatory homeostasis [15, 62, 
74, 84]. Inflammation is tightly regulated, as injury / infection requires a quick response in the 
form of physiological changes at the site of injury / infection as well as a quick reversion of the 
response to its former physiological state. An inability to revert leads to chronic inflammation 
generally associated with several disease states [1-5]. Thus, cytokines are soluble intercellular 
regulatory proteins that play a critical role in mediating the inflammatory response by acting as 
paracrine, endocrine, or autocrine hormones. Cytokines are secreted by leukocytes, as well as 
tissues such as muscle, and bind extracellular receptors on target cells to induce activation of 
second messenger systems, leading to specific gene transcription [107]. Pro-inflammatory 
cytokines are generally acute phase stimulants that signal to the hypothalamus to increase body 
temperature through the production of prostaglandins of group E (PGE2) as well as acting to 
alter metabolism and gene regulation within tissues such as the liver [99]. Pyrogenic pro-
inflammatory cytokines include: IL-1β, IL-6, and TNFα.  
 IL-6: IL-6 is both a cytokine and myokine, meaning it’s released from immune cells and 
myocytes [41, 108]. Its role in the inflammatory response is, at best, controversial. In myocytes, 
it is known to correlate with energy mobilization and body temperature [109]. IL-6 acts by 
binding cytokine receptors that activate the Janus kinase-signal transducers and activators of 
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transcription (JAK-STAT) pathway [110]. The IL-6 receptor is a homodimer found within the 
plasma membrane in which each protein possesses a single-pass transmembrane [111]. 
Activation of the receptor activates associated JAK molecules that in turn phoshorylate the 
cytokine receptor [111], Phosphorylation of the cytokine receptor recruits proteins containing 
phosphotyrosine-binding Scr homology 2 (SH2) domains, such as STATs. Recruited STATs are 
also phosphorylated by JAK molecules at the site of the receptor, forming a scaffold for the 
binding and phosphorylation of additional STATs [110]. STATs form homodimers that 
translocate to the nucleus and act as transcription factors. Negative regulation of cytokine 
receptors occurs by inhibiting STAT phosphorylation, involving suppressors of cytokine 
signaling (SOCS), mechanically blocking activated STAT at the promoter region by protein 
inhibitors of activated STATs (PIAS), or by dephosphorylation of cytokine receptors and STATs 
by protein tyrosine phosphates [110].  
 IL-10: Upregulation of the pro-inflammatory cytokines leads to significantly increased 
circulating numbers of monocytes, lymphocytes, and granulocytes [41-42] and a subsequent 
induction and upregulation of anti-inflammatory cytokines. IL-10 is an anti-inflammatory 
cytokine that acts to inhibit the release of the inflammatory cytokines, TNFα, IL-6, and IL-1β, 
from monocytes and macrophages [8] as well as block neutrophil activation [99], thus alleviating 
inflammation at the site of injury / infection. Once IL-10 binds its receptor, the JAK-STAT 
signaling pathway is activated. Jak2 and Tyk2, both tyrosine kinases, are activated and 
phoshporylate the transcription factors STAT1, STAT2, and STAT5, ultimately controlling gene 
expression. IL-10 is thought to inhibit pro-inflammatory responses of the cell by inhibiting NF-
kB activity [63]. 
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2.2.3 Acute Phase Protein: CRP 
 CRP is an acute phase protein secreted mainly by the liver in response to inflammatory 
stimuli as part of the acute phase reaction within the immune system [112]. CRP is known to 
bind to low density lipoprotein (LDL),  at type of cholesterol that is increased in atherosclerosis, 
and thus CRP plays a role in atherogenesis [113]. Large chronic increases in plasma CRP levels 
are now commonly used as a marker of inflammation and as a possible risk factor for CVD 
[113]. Upregulation of CRP production and secretion from hepatocytes is dependent on the 
presence of the pro-inflammatory cytokine, IL-6 [114]. IL-6 may be released from systemic 
immune cells, including monocytes and macrophages, and upregulates transcription factors, such 
as C/EBPβ, that are needed for CRP transcription [115]. Regulation of IL-6 levels may also lead 
to regulation of CRP levels at the transcriptional level. Additionally, measure of CRP plasma 
levels may be a better indicator of inflammation in resting plasma samples due to its persistent 
upregulation during chronic inflammation, unlike more transient cytokines such as IL-6 or IL-10 
measurements in plasma, whose levels appear to be more transient in nature. 
2.2.4 Pro-inflammatory Cytokines and the CNS Connection in the Periphery 
Intercommunication between the nervous system and the lymphatic tissues exists, where 
the CNS, particularly the hypothalamus-pituitary-adrenocortical axis (HPA), controls the 
immune and inflammatory responses through the use of complex pathways involving 
electrochemical signals [83, 89, 116]. This interconnecting web of pathways has been 
demonstrated in many publications using lipopolysaccharide (LPS), a protein found on the outer 
membrane of gram-negative bacteria, to mimic bacterial infection and immunostimulation [83, 
89, 117]. Whole body responses to LPS include release of IL-1β and TNFα from macrophages 
and, consequently, an increase in T-lymphocyte cell activation [118-119]. T-lymphocytes then 
secrete IL-6, increasing the number of activated macrophages, leading to increased secretion of 
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pro-inflammatory cytokines [120].  Furthermore, studies show that IL-1β, TNFα, and IL-6 are all 
potent stimulators of the HPA axis. When rats are injected intracranially or peripherally 
(subcutaneous) with LPS, there is an acute upregulation of plasma ACTH and corticosterone 
levels and pro-inflammatory TNFα, IL-6, and IL-1β protein levels [83, 89]. This same response 
can be seen in human whole blood samples exposed to LPS [62]. The existing data suggest that 
the first pro-inflammatory responder to LPS is TNFα followed by IL-1β and IL-6. Chronic 
stimulation with LPS leads to attenuation of ACTH and corticosterone circulating plasma levels 
with chronically upregulated circulating IL-1β levels but not IL-6 or TNFα [83, 89]. The chronic 
hypersecretion of IL-1β seen with LPS injection creates a blunted and short-lived acute response 
of rats to LPS injection [83]. It has also been shown that a reciprocal pathway between the HPA 
and periphery occurs, where stimulation of neurons with IL-1β, TNFα, or IL-6 leads to secretion 
of corticotrophin-releasing hormone (CRH) and, subsequently, ACTH [84]. Similar 
inflammatory responses occur within the systemic circulation and CNS in response to LPS 
stimulation. 
2.2.5 Anti-inflammatory Cytokine IL-10 in the Periphery and CNS 
Interleukin 10 is an anti-inflammatory cytokine produced by macrophages in response to 
LPS stimulation. IL-10 is referred to as an anti-inflammatory cytokine because it acts to inhibit 
the release of the pro-inflammatory cytokines, TNFα, IL-6, and IL-1β, from monocytes and 
macrophages [8].  Peripheral administration of IL-10 in rats causes inhibition of IL-1β secretion 
in response to LPS stimulation in the brain stem and periphery but not the hypothalamus [9]. 
Conversely, central administration of IL-10 causes inhibition of IL-1β secretion in response to 
LPS stimulation in the hypothalamus and brain stem but not in the periphery [9]. This suggests a 
major role of IL-10 in subduing activation of the HPA axis in response to pro-inflammatory 
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cytokines, where pro-inflammatory cytokines, such as IL-1β, in the periphery cause activation of 
the HPA and secretion of corticotrophin-releasing factor (CRF), ACTH, and POMC.  
2.3: Melanocortin Receptors in the Central Nervous System 
2.3.1 Melanocortin Receptors are G Protein Coupled Receptors 
Melanocortin receptors belong to a family of intramembrane receptors known as G 
protein coupled receptors (GPCRs). GPCRs possess 7 transmembrane domains, with an 
extracellular ligand binding site and an intracellular carboxy terminus linked to a G protein 
[121]. Activation of the receptor occurs when ligand binds and the associated G protein is 
activated. G proteins exist as heterodimers consisting of three separate subunits; Gα, Gβ, and Gγ 
[122]. Over twenty different isoforms of Gα subunit can be found in mammalians, all of which 
bind to guanine nucleotides, both guanine diphosphate (GDP) and triphosphate (GTP) [122]. In 
the case of MCRs, Gαs (s meaning stimulatory) is the isoform activated when ligand binds to the 
receptor. Gαs, formerly associated with GDP, undergoes an allosteric change that allows GTP to 
replace GDP in the guanine nucleotide binding site and Gαs dissociates from Gβ and Gγ. Gαs 
plus GTP then activate the enzyme, adenylyl cyclase [123]. GTP is hydrolyzed to GDP by the 
GTPase activity of Gαs and adenylyl cyclase converts ATP to cyclic AMP (cAMP) [124]. The 
now inactive Gαs associates with the Gβ and Gγ subunits again, the receptor is phosphorylated to 
reduce its response to ligand [125]. cAMP is a second messenger that causes amplification of the 
ligand’s effect on the cell by activating cAMP response element binding factor (CREB) and 
protein kinase A (PKA) [126]. CREB is a transcription factor that binds to the nucleic acid 
sequence 5’-TGACGTCA-3’ within the promoter region of various genes causing their 
subsequent upregulation [65].  
In addition to the upregulation of the cAMP second messenger system, evidence exists to 
suggest that activation of several MCRs (MC2R and MC3R) by ligand activates other second 
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messenger systems involving inositol phosphate (IP3) and intracellular calcium (Ca) [127]. 
Upregulation of the IP3 / Ca second messenger is indirectly related to upregulation of cAMP 
production in agonist-stimulated MC3R transfected cells. PKA is a negative regulator of IP3 / 
Ca, thus induction of MCR and subsequent increases in intracellular cAMP, leading to 
concominant increases in PKA, may be the regulatory pathway controlling inhibition of IP3 / Ca 
upregulation after MCR stimulation [127]. The third transmembrane domain of MCR is thought 
to be the regulatory loop of the receptor that couples to the necessary G protein, conferring 
upregulation of specific, separate second messenger systems [127]. One explanation for the 
dependence of the specific systems is a post translation modification, such as phosphorylation of 
the third transmembrane loop. Increases in PKA may lead to phosphorylation of the regulatory 
domain of MCR, changing the conformation of the protein and leading to the binding of different 
G protein subunits with subsequent upregulation of separate second messenger systems.  
2.3.2 Melanocortin Receptors and Metabolism: MC3R and MC4R 
The brain is the most complex organ of the body and is involved in many functions, 
including intercepting and interpreting endocrine signals from other organs. Specifically, the 
hypothalamus is considered the central unit of satiety comprehension and metabolic signaling 
[80, 85, 128-130]. The brain is a major player in the battle against obesity and T2D. It is known 
from extensive research on the arcuate nucleus (ARC) and lateral hypothalamus that there are 
specific neurons, POMC neurons, which receive endocrine signals from peripheral adipose tissue 
in the form of hormones [80, 85, 128, 131]. Leptin is one such hormone which binds to receptors 
located on the POMC neurons [80, 128, 131]. Leptin is an endocrine hormone secreted from 
adipocytes, the circulating amount of which is directly dependent on the amount of adipose 
tissue present. Leptin travels through the blood stream, crosses the blood brain barrier, and binds 
to leptin receptors located on the plasma membrane of POMC neurons. Once bound, the protein 
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POMC is released from the neurons and later proteolytically cleaved into various differing 
peptides, including: ACTH, α, β, and γ-MSH [132]. ACTH, β-MSH, and α-MSH are all agonistic 
peptides able to bind the melanocortin 3 (MCR3) and 4 (MCR4) receptors, located in the ARC, 
lateral hypothalamus, dorsomedial hypothalamic nucleus (DMH), and the PVN of the 
hypothalamus [79, 132]. The MC3R and MC4R are also under the control of agonistic 
competition through the effects of agouti-related peptide (AgRP) and neuropeptide Y (NPY), 
peptides also released by neurons in the hypothalamus and controlled by leptin expression [80, 
85, 128-130]. When leptin is present in the brain and the MC3R and MC4R are bound by their 
agonistic peptides, the sympathetic nervous system (SNS) is stimulated to release norepinephrine 
(NE) leading to increased thermogenesis and energy expenditure as well as inhibition of food 
intake [86, 133], positively correlating with an increase in lipolysis and fatty acid oxidation [134-
135]. When leptin is absent, AgRP binds to MC3R and MC4R, preventing agonists from binding 
[136], whereas NPY binds to separate receptors located on the POMC neurons, antagonizing the 
release of agonistic peptides [137]. Under antagonistic conditions, hyperphagia ensues, energy 
expenditure decreases, and fatty acids are converted to triglycerides for storage in adipose tissue.  
Although the pathway of leptin signaling in the brain seems complete, our understanding 
of the mechanisms underlying the roles of MC3R and MC4R are not fully understood and the 
distinct actions of each receptor with regards to nutrient sensing, satiety, and metabolism remain 
to be elucidated. Thus, it becomes necessary to speak of both receptors when the role of one 
receptor is being examined. Extensive studies have found that mice lacking the MC4R are 
hyperphagic, eating as much as three times that as WT mice, hypometabolic, and exhibit 
increased body weight as well as increased fat mass [87-88, 138-140]. MC3R knock out (KO) 
mice also develop increased fat mass, although this occurs through a different mechanism than 
that of MC4R KO mice. MC3R KO mice are not hyperphagic, hypometabolic, or overweight. 
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Instead they exhibit differences in nutrient partitioning, where fat free mass (FFM) is sacrificed 
in order to conserve and even increase fat mass (FM) [87-88, 139]. Furthermore, when injected 
with leptin, MC4R KO mice exhibit ablation of hyperphagia with compromised SNS activation, 
whereas MC3R KO mice show full activation of the SNS with failure of leptin to reduce food 
intake [86]. When MC4R KO mice are fed a diet with moderate (7%) increases in fat, metabolic 
efficiency is further exacerbated, leading to larger increases in adiposity [87, 141-143]. When 
MC3R KO mice are fed a diet with moderate (7%) increases in fat they still do not exhibit 
increases in body weight or become hyperphagic, although they do exhibit increases in adiposity 
and metabolic efficiency [87, 141-143]. 
Thus, it is obvious that MC4R and MC3R are mediators not only in food intake and SNS 
activation, but also in nutrient partitioning, and metabolic efficiency. The separate roles of each 
remain to be completely elucidated, but it can be concluded that, generally, MC4R is used in the 
comprehension of satiation and food intake, whereas the MC3R is mainly used in the 
comprehension of nutrient composition of food and subsequently nutrient partitioning.  
2.4. Melanocortin Receptors and the Immune Response 
The immune response is greatly interconnected with various parameters of metabolism, 
where metabolic pathways are highly regulated, independent of metabolic changes, during  
inflammation. Disturbance in metabolic homeostasis can lead to hypoxia, decrease in 
intracellular pH, release of lysosomal enzymes, disruption of cell membranes, and decreased 
mitochondrial function. Dysfunctional mitochondria are the cause of impaired oxidative 
phosphorylation and insufficient ATP production [144-146]. Cells must utilize anaerobic 
respiratory pathways, glycogen, and creatine phosphate stores to create ATP for survival. 
Depletion of glycogen and creatine phosphate rapidly occurs, leading to accumulation of 
intracellular sodium and water in addition to potassium leakage [146]. Protein synthesis halts as 
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a result of damaged endoplasmic reticulum and ribosomes. Calcium accumulates in the 
mitochondria and necrosis of the cell occurs. This process is recognized by the body as cellular 
damage and induces the inflammatory response [99]. The inability to maintain metabolic 
homeostasis has been associated with infection and inflammation and is generally believed to be 
the product of changes in cytokine expression rather than the initiators of changes in cytokine 
expression. Therefore, researchers hypothesize that low level chronic inflammation may actually 
precede the manifestation of several diseases, such as T2D, metabolic syndrome, and cancer. 
2.4.1 Melanocortin Receptors and the Immune Response in the CNS: MC3R 
The melanocortin system, meaning the POMC neurons and MCRs and their agonists and 
antagonists, is one pathway that is highly regulated in the CNS to control metabolic homeostasis 
as well as inflammation. It has been shown that LPS injections increase production of leptin from 
peripheral adipose tissue and decreases food intake in hamsters. Futhermore, injections of TNFα 
or IL-1 also increase secretion of leptin from epididymal white adipose tissue (EWAT) despite 
decreases in food intake [147-148]. As stated previously, leptin is an endocrine hormone that 
travels through the blood from peripheral adipose tissue to the brain, where is can bind leptin 
receptors on POMC neurons, leading ultimately to activation of MC3R. In addition to increased 
secretion of leptin from adipose tissue, intraperitoneal injections of human IL-1β in rats increase 
plasma ACTH levels with a concomitant decrease in ACTH anterior pituitary levels, increases in 
POMC mRNA in the anterior pituitary, and no difference in CRF in the hypothalamus [149]. It 
has also been shown that CRF directly upregulates POMC expression in the anterior pituitary 
[149]. In studies using the AtT-20 corticotroph tumor cell line, it has been shown that IL-6 and 
Il-1β, but not TNFα, significantly upregulate ACTH secretion [150]. In the same study, by 
luciferase assay, CRH increases POMC promoter activity. Promotor activity is also minimally 
upregulated with TNFα, IL-6, or IL-1β, but when CRH is added along with either cytokine, the 
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effects of CRH alone on POMC promoter activity are potentiated [150]. Thus, modulation of the 
HPA axis during the immune response can be initiated by cytokines in the hypothalamus or 
pituitary, causing activation of POMC neurons by leptin, transcription and secretion of POMC 
by IL-6, IL-1β, TNFα and CRH, leading to increased ACTH secretion by protease activity of the 
POMC peptide. Speculation leads to the conclusion that MC3R activation by ACTH or its 
derivative peptide, α-MSH, in the HPA axis is important in mediating pro- and anti-
inflammatory responses as well as associated diseases, including obesity. 
2.4.2 Melanocortin Receptors and the Immune Response in the Periphery: MC1R, MC3R, 
and MC5R 
 
The role of MCRs in the inflammatory response extends from the CNS to peripheral 
tissues where MC3Rs are known to exist on granulocytes, lymphocyres, macrophages, and 
monocytes [67, 82]. The inflammatory and metabolic pathways involving the MC3R in the CNS 
is mimicked in these peripheral immune cells, especially macrophages. POMC is expressed in 
lymphocytes subpopulations and monocytes [67]. POMC-derived ACTH, α-MSH, β-MSH, and 
γ-MSH are also expressed within immune cells, including lymphocytes. Studies show that 
activation of MC3R on macrophages by α-MSH or ACTH inhibits IL-6 and TNFα production in 
macrophages [7, 75]. In human monocytes, there is an increase in α-MSH production in response 
to IL-6 or TNFα stimulation [151]. Though macrophages are known to possess both MC1R and 
MC3R, and both are activated by ACTH and α-MSH, recent studies indicate that MC1R or the 
MC3R on macrophages are sufficient in mediating the peripheral anti-inflammatory response in 
monocytes and macrophages while the function of MC5R on monocytes / macrophages remains 
unknown [69-70].  
Other recent studies have explored the role of MCRs in inflammation by using the MC4R 
KO and MC3R KO mouse models. MC4R KO mice exhibit increased macrophage infiltration 
into adipose tissue, a phenomenon normally associated with inflammation. In addition, when 
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placed on a high fat diet where MC4R KO mice become extremely obese, macrophage 
infiltration in adipose tissue is exacerbated and chronic inflammation ensues, leading to insulin 
resistance [152-153]. On the other hand, MC3R KO mice only become obese when placed on a 
high fat diet, yet an increase in macrophage number within the adipose tissue of obese MC3R 
KO mice is not seen nor is an upregulation of TNFα mRNA [152-153]. One explanation is that 
the MC3R presence on macrophages and within the CNS is crucial for the inflammatory 
response to take place. Thus, it is clear that the role of MC3R in mediating the immune response 
is necessary in the CNS as well as in peripheral tissues, and these pathways are intertwined.  
In order to fully understand the biological mechanisms underlying the immune response 
and how we can manipulate the response in order to help diseased individuals, it is necessary to 
study the connections between the immune response in the CNS and periphery. Studies have 
extensively shown that activation of the POMC neurons occurs during inflammation in response 
to pro-inflammatory cytokines; IL-6, IL-1β, and TNFα [154-155]. This translates to increased 
ACTH secretion in the hypothalamus [154]. Studies also show that circulating POMC and 
ACTH levels are increased during inflammation [154-155]. In other independent studies, it is 
known that macrophages, responders to stress and initiators of the immune response, possess 
MC3Rs. MC3R are important in regulation of metabolic responses in the CNS. They are 
activated by various derivatives of POMC, including ACTH, α-MSH, β-MSH, and γ-MSH, in 
the hypothalamus. Furthermore, MC3Rs on cultured peritoneal macrophages show activation in 
response to stress, mimicking the response of MC3R in the CNS. In response to activation at the 
MC3R, macrophages secrete IL-10, an anti-inflammatory cytokine, which in turn inhibits 
secretion of IL-6, IL-1β, and TNFα from macrophages. Additionally, activation of the MC1R on 
macrophages shows a redundant role of these MCRs in mediating the anti-inflammatory 
processes of macrophages. It remains unclear if the MC1R and MC3R may be activated in 
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response to different external stimuli or cause differential cellular processes to occur, as both 
receptors are able to bind the same agonists and seem to elicit the same cellular responses. 
Hence, research that focuses on the changes of MC1R and MC3R during acute and chronic 
inflammation will help to elucidate the mechanisms behind MCR activation and their subsequent 
effects on infection and disease, providing the necessary connection between peripheral and 
central inflammatory pathways and disease prevention.  
2.5 Effects of Exercise on the Immune System 
2.5.1 Effects of Exercise on Inflammation Related Disease Development 
Exercise is an easily controlled and utilized form of therapy for many diseases, such as  
T2D, atherosclerosis, metabolic syndrome, and CVD. A major therapeutic effect of regular 
exercise is its potential to decrease inflammation, as some of the most prominent diseases in 
today’s society coincide or are preceded by the presence of chronic inflammation. For instance, 
CVD is currently the leading cause of death in Western countries, accounting for approximately 
40% of annual deaths in the United States. There are several forms of CVD; coronary heart 
disease (CHD), cerebrovascular disease, hypertension, heart failure, and rheumatic heart disease. 
The leader in deaths amongst the various forms of CVD is CHD, with CHD killing 
approximately 445,687 deaths in 2005 alone [77]. Development of CHD involves 
atherosclerosis, a buildup of plaque in the arteries that leads to luminal narrowing and decreased 
compliance. Initiation of atherosclerosis begins with injury and endothelial dysfunction, causing 
recruitment of leukocytes, specifically monocytes, to the area. Monocytes then migrate into the 
intima of the vessel wall, where they mature into macrophages and begin endocytosis of low 
density lipoprotein (LDL) cholesterol [156-157]. Once LDL cholesterol molecules are engulfed 
by the macrophage, the cell is referred to as a foam cell. Foam cells remain present in the intima 
chronically and increase in number over time. Eventually, the foam cells form plaque within the 
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vessel walls. Atherosclerosis is initiated as an inflammatory response to injury of the vessel and 
proceeds into chronic inflammation of the area [158]. Build up of plaque causes decreased 
responsiveness of the vessel to stimuli that normally control dilation of the vessel and 
compliance to changes in blood pressure [159]. Additionally, dislodging of the plaque from the 
vessel wall into the circulation may cause vascular blockage and tissue ischemia, stroke, or 
death. Because initiation of atherosclerosis is believed to be due to injury and subsequent 
recruitment of monocytes as well as additional leukocytes to the area, CHD is largely controlled 
by inflammatory cells and cytokines [57].  
Whereas CHD is the number one killer of Americans, T2D was listed in 2005 as the 
seventh leading cause of death in the United States. T2D may be correlated with CHD, as 68% 
and 16% of the T2D deaths in 2005 in people aged 65 or older also exhibited heart disease and 
stroke, respectively [160]. Additionally, 75% of those diagnosed with T2D also possess 
hypertension. Given that CVD and T2D appear to afflict the same populations, it is no surprise 
that T2D is also linked to chronic low-grade inflammation. Diabetics exhibit increased levels of 
blood glycoproteins, acute phase proteins, and elevated leukocyte counts [161-163]. Elevated 
cytokine levels themselves are thought to be a predictor of T2D [163]. Furthermore, elevated 
levels of inflammatory cytokines are positively correlated with insulin resistance, the 
distinguishing factor in type 2 diabetics. Also correlated with T2D is obesity, a major cause of 
metabolic syndrome [164]. Obesity promotes inflammation in adipose tissue as well as the 
circulation. It is thought that obesity-related inflammation can lead to insulin resistance and 
further tissue damage in the pancreas [165]. Thus, obesity may be an underlying factor in the 
etiology of T2D that creates a vicious cycle of chronic inflammation and insulin resistance.  
Closely related to T2D, metabolic syndrome is a newly recognized disease that 
encompasses several of the risk factors seen not only in T2D but also in CHD. Metabolic 
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syndrome, also referred to as syndrome X or dysmetabolic syndrome, is characterized by 
abdominal obesity, insulin resistance or glucose intolerance, hypertension, dyslipidemia, and, 
most notably, inflammation. It was estimated that in 2007 approximately 76 million people in the 
United States can be classified as having metabolic syndrome [77]. Coincidently, 44% of obese 
adolescents develop metabolic syndrome [77].  One of the most highly associated factors of 
metabolic syndrome is chronic inflammation. Sufferers of metabolic syndrome exhibit high 
levels of circulating pro-inflammatory cytokines, including IL-6 and TNFα [166]. Because 
obesity is a major contributing factor to metabolic syndrome, it is plausible that chronic 
inflammation associated with metabolic syndrome is a direct result of increased adiposity. 
Several researchers note an association between obesity and chronic inflammation, with some 
hypothesizing that the pro-inflammatory state of adipose tissue is a precursor to obesity [166].  
As some of the most prevalent diseases in today’s society all involve a state of low level 
chronic inflammation, reduction in risk factors for these disease states all include increasing 
physical activity. Indeed, a large body of evidence that shows an inverse relationship between 
increased physical activity levels and decreased inflammation supports the anti-inflammatory 
effects of exercise. Studies show that fitness level is a stronger predictor for death than smoking, 
high cholesterol, and diabetes [167]. Notably, exercise alone can increase high density 
lipoprotein (HDL) cholestrol and insulin sensitivity, improve body composition, and decrease 
plasma triglycerides, cholesterol, blood pressure and inflammatory cytokines [13, 159, 168-169]. 
Studies show that those who take part in a regular exercise program have much lower incidence 
of CHD than sedentary counterparts [167]. Additionally, development of CHD in physically 
active populations, if it does occur, has been shown to be less severe and develop at a later age 
[167]. Exercise promotes insulin independent uptake of glucose into working muscles, helping to 
control plasma glucose levels [170]. As a result, tissues become more insulin sensitive over time 
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[167]. Physical activity helps to alleviate insulin resistance in T2D and metabolic syndrome, 
even allowing some diabetics to lower or stop taking medications related to these diseases. 
Exercise decreases circulating levels of pro-inflammatory cytokines, such as those associated 
with T2D, obesity, and metabolic syndrome [171-172]. Not only is exercise an excellent 
therapeutic strategy to alleviate the development of a multitude of diseases, but it is also an 
excellent model to use in the study of the immune response due to its ease of implementation and 
few detrimental side effects.  
2.5.2 Effects of Exercise on Pro and Anti-Inflammatory Cytokines in Peripheral Tissues 
During exercise, there is tissue injury leading to inflammation. Thus, the effects of 
exercise mimic the initiation of the immune response. During muscle contraction, IL-6 is 
secreted from myocytes as well as systemic leukocytes. IL-6 is known to activate macrophages, 
leading to secretion of IL-1β and TNFα. Secretion of IL-1β and TNFα recruit other immune cells 
to the site of injury.  The inflammation associated with exercise is generally referred to in two 
separate phases, the acute and chronic phases. Acute changes in inflammation occur immediately 
post exercise and can continue for over four hours after the completion of exercise [15]. Chronic 
changes in inflammation can last for weeks or months after chronic, recurring exercise. The two 
phases are distinctive from each other due mainly to the differences in cytokine expression. 
During acute phase, local tissue injury causes upregulation of circulating and muscle specific 
pro-inflammatory cytokines, including IL-6, IL-1β, and TNFα [15, 108]. Upregulation of the 
pro-inflammatory cytokines in turn leads to significantly increased circulating levels of 
macrophages, NK cells, monocytes, lymphocytes, granulocytes, T-helper, and T-cytotoxic cells 
[41-42].  Acute exercise also induces increased activity of macrophages [42]. Mechanisms 
underlying the acute increase in pro-inflammatory secretion observed following exercise can be 
contributed to activation of the p38 mitogen activated protein kinase (MAPK) and nuclear factor-
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Κβ (NF-Κβ) pathways [147].  MAPKs are serine / threonine kinases that are responsible for 
controlling gene expression through phosphorylation of various proteins, including nitric oxide 
synthase (NOS). NOS is responsible for producing NO, which has antimicrobial and tumoricidal 
activity, in macrophages. NF-Κβ is a transcription factor responsible for enhancing NO 
production in macrophages by enhancing transcription of NOS [173].    
Generally, after chronic exercise, there is an increase in circulating levels of IL-10, 
leading to decreased secretion of pro-inflammatory cytokines, IL-1α and TNFα [11]. There is 
also increased sensitivity of macrophages to stimuli and increased levels of NO production [10]. 
Although there may also be an increase in IL-6 during chronic exercise, this may be due to the 
fact that IL-6 is both a myokine (secreted by myocytes) and a cytokine. In fact, it has been 
postulated that the production of IL-6 from muscle during exercise induces the secretion of IL-
10. IL-10 may then act to decrease circulating levels of IL-1β and TNFα [34].  
2.5.3 Effects of Exercise on CRP 
Several studies support the role of exercise in decreasing circulating CRP levels [38, 174-
177]. While studies utilizing aerobic exercise interventions show beneficial effects of exercise in 
lowering body weight, adiposity, and increasing fitness, aerobic exercise has not been shown to 
create the same level of favorable changes in CRP levels as resistance training [38, 174-177]. For 
example, our lab, in conjunction with Dr. Tim Church’s lab at Pennington Biomedical Research 
Center, has shown that 6 months of regular aerobic exercise at incremental doses of (50%, 100%, 
and 150%) of the NIH Consensus Panel physical activity recommendation on cardiorespiratory 
fitness failed to reduce CRP in healthy, overweight/obese postmenopausal women [37, 178].   
Conversely, several independent studies have shown that resistance training significantly 
decreases CRP levels, decreases IL-6 and IL-1β concentrations, increases the anti-inflammatory 
cytokine IL-10, and induces overall alterations in chronic inflammation [39, 174-175]. Given 
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that CRP is transcriptionally regulated by the presence of IL-6 [15, 47, 50], resistance training 
induced alterations in CRP transcription and translation may be aided by alterations in the pro-
inflammatory cytokine, IL-6 as well as IL-1β. IL-6 and IL-1β production from monocyte / 
macrophages is further negatively impacted by the synthesis and production of the anti-
inflammatory cytokine, IL-10 [15]. Thus, even in younger, healthy populations, it appears that 
resistance training exerts the most beneficial effects on chronic inflammation by changing 
circulating inflammatory cytokine profiles and inducing changes in global markers of 
inflammation, such as CRP. 
2.5.4 Effects of Exercise on Inflammation in the CNS 
Given the relationship between the CNS and periphery in the inflammatory response, it’s 
no surprise that exercise exerts its effects not only in peripheral tissues but also through signaling 
pathways in the CNS. Exercise, like IL-1β, activates CRH neurons in the hypothalamic PVN 
[89]. PVN neurons in turn project to the hypophyseal portal system and noradrenergic neurons in 
the brainstem and POMC neurons in the hypothalamus. Thus, induction of CRH neurons as a 
result of exercise leads to the release of the neurotransmitters, NE and epinephrine (Epi), as well 
as activation of the POMC neurons that secrete α-MSH and ACTH. Exercise also causes an 
increase in MC3R mRNA in the hypothalamus [179]. In the periphery, NE inhibits TNFα and 
IL-6 production through activation of beta adrenergic receptors (β-AR) in human whole blood 
extracts stimulated with LPS [62]. Studies also show that isoproteronol, a β-AR agonist, inhibits 
TNFα but not IL-6 production after exercise [41-42]. Furthermore, it is known that muscle 
secretes IL-6 in response to contraction. Thus, it appears that the peripheral changes seen during 
exercise may stimulate the pathway associated with the immune response in the CNS, which in 
turn may regulate peripheral inflammation during the acute and chronic phases of exercise. 
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2.6 Immune Cell Response to Exercise 
2.6.1 Population Response to Exercise 
Acute bouts of exercise not only lead to an increase in inflammatory cytokine secretion  
from leukocytes in the periphery, but also lead to acute leukocytosis, or increased leukocyte 
recruitment into the circulation [14, 20]. The increases seen are proportionally related to the 
intensity of the exercise bout [23]. It is believed that increases in circulating leukocytes are due 
to increases in SNS stimulation, and leukocytosis is largely due to increases in NK cells and 
neutrophils [14, 20-21, 25]. Muscle damage that occurs during an exercise bout, causing NK cell 
and neutrophil recruitment, induces release of pro-inflammatory cytokines into the circulation 
and recruitment of other leukocytes to the area. After the exercise bout, macrophages become the 
predominant leukocyte type in the damaged muscle [180]. Furthermore, pro-inflammatory 
cytokines are replaced by anti-inflammatory cytokines being released from the newly activated 
macrophages. Macrophages may remain within the tissue, releasing cytokines, for up to fourteen 
days after the exercise bout, whereas neutrophils are transiently recruited for up to twenty-four 
hours after the exercise bout [29]. Studies report that activated neutrophils and macrophages 
release the pro-inflammatory cytokines IL-1β and TNFα up to 5 days after an exercise bout [29]. 
These transient systemic increases in pro-inflammatory cytokines acutely after exercise may be 
attributed to secretion from contracting myocytes instead of secretion from recruited leukocytes 
[181]. Support for this hypothesis has been documented in several studies that reveal that acute 
spontaneous cytokine production within circulating monocytes is not the source of increased 
TNFa or IL-6, although these cytokines are significantly elevated in serum after exercise [21]. 
Transient increases in pro-inflammatory cytokines, whether initially produced from circulating 
monocytes or contracting myocytes, lead to recruitment and activation of leukocyte 
subpopulations, resulting in possible production and secretion of pro-inflammatory cytokines 
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from monocytes. Furthermore, activation of monocytes by pro-inflammatory cytokines, 
independent of their source of production, will result in changes in anti-inflammatory cytokine 
production from activated monocytes. Evidence shows that, acutely, exercise simultaneously 
upregulates circulating levels of pro-inflammatory cytokines as well as anti-inflammatory 
cytokines and pro-inflammatory cytokine “inhibitors” [23, 25, 27, 29, 33].  The hypothesis of 
simultaneous secretion is that muscle contraction leads to the production of the pro-inflammatory 
cytokines, recruiting and activating leukocytes, which in turn produce and secrete anti-
inflammatory cytokines [29].  
Contrary to the acute manifestations of exercise, chronic, recurring bouts of exercise 
lead to an overall decrease in inflammation, evidenced by decreased recruitment of leukocytes 
into the circulation as well as increased sensitization of macrophages to inflammatory stimuli 
[17]. One of the first endocrine responses to an exercise bout is an increase in the secretion of 
Epi and NE from the adrenal glands. Increases in SNS output help to increase heart rate, cardiac 
output, oxygen uptake and metabolism and acts to maintain homeostasis of oxygen uptake to 
carbon dioxide production, waste production to waste removal, and heat production to heat loss. 
Chronic exercise training may lead to a desensitization of leukocytes by downregulation of 
receptors, specifically β-ARs, the receptors responsible for responsiveness of leukocytes to SNS 
activation [182]. Thus, chronic recurring bouts of exercise leads to attenuated recruitment of 
certain leukocyte subpopulations into the circulation after an acute bout of exercise. It is 
plausible that exercise exerts its anti-inflammatory effects, alleviating chronic inflammation, by 
effectively decreasing leukocyte recruitment to inflamed areas. Indeed, studies suggest that after 
repeated bouts of exercise, neutrophil recruitment to damaged muscle is attenuated by 10-45% 
and inflammatory response receptor presentation is altered [29]. Recruitment of leukocytes may 
be largely dependent on ß-AR stimulation by catecholamines, as blockade of the ß2-AR by 
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antagonist ameliorates recruitment of monocytes and lymphocytes acutely post exercise [59-
60]. Furthermore, catecholamine stimulation decreases whole blood levels of TNFa and IL-1ß 
and increases secretion of IL-10 from macrophages [61-62]. Another viable hypothesis of 
exercise-mediated decreases in chronic inflammation may be that the transient increases in 
catecholamine and pro-inflammatory cytokine release seen acutely leads to activation of 
macrophage plasma receptors and anti-inflammatory pathways affectively dowregulating pro-
inflammatory cytokine production. 
2.6.2 Classically Activated vs. Alternatively Activated Macrophages vs. Type II Activated 
Macrophages 
 
Macrophages exert differential effects through activation of divergent pathways, pro- or 
anti-inflammatory. Differential effects are a result of a complex hierarchy of macrophage 
phenotypes, activation, and pathways. Currently, three macrophage phenotypes are recognized; 
classically activated, alternatively activated, and type II activated macrophages. Classically 
activated macrophages are characterized by Th1 type response to inflammation, meaning they 
work to recruit other immune cells to the site of injury, release pro-inflammatory cytokines such 
as interferon gamma (IFNγ), degrade extracellular matrices, and promote apoptosis [183-184]. 
Conversely, alternatively activated macrophages are characterized by a Th2 type response, 
release anti-inflammatory cytokines such as IL-10, construct extracellular matrices, and 
promote angiogenesis [184]. A critical balance between pro- and anti-inflammatory statuses is 
maintained by the recruitment of differential macrophage phenotypes to an injured area [183].  
Differentiation of macrophages into classically versus alternatively activated is 
dependent on activation of priming pathways through binding of circulating proteins to plasma 
receptors on the macrophages. IFNγ, once bound to IFNγ membrane receptors, is an adequate 
priming factor for classically activated macrophages. After being primed macrophages then 
commit to the classically activated pathways when challenged by inflammatory stimuli such as 
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LPS. Classically activated macrophages are responsible for eliciting significant tissue damage 
when unchecked by promoting degradation of tissue as well as promoting chronic inflammation 
in the area. Alternatively activated macrophages are used by the body to balance the 
inflammatory response, counteracting the effects of classically activated macrophages. 
Alternatively activated macrophages release anti-inflammatory cytokines leading to prevention 
of chronic inflammation and tissue destruction [184]. Alternatively activated macrophages do 
not require priming before committing to the alternative pathway; instead circulating cytokines 
interleukin 4 (IL-4), interleukin 13 (IL-13), or glucocorticoids seem to be sufficient in activating 
alternative macrophages [184]. When activated, these macrophages also undergo morphological 
changes, recruit leukocytes to the injured area, and secrete several factors involved in promoting 
extracellular matrix construction as well as cell proliferation [183]. 
In addition to classically and alternatively activated macrophages, scientists now 
recognize a third macrophage phenotype, the type II activated macrophage [184]. Type II 
activated macrophages are characterized by altered cytokine release upon stimulation. 
Stimulation causes downregulation of interleukin 12 (IL-12) and increased secretion of IL-10, 
which in turn causes secretion of IL-4 from T cells.  Activation of type II macrophages requires 
ligation of the Fc receptors for immunoglobulin G (IgG) (FcγR) by antigen IgG complexes plus 
inflammatory stimuli. Both unprimed and IFNγ primed macrophages may be stimulated to  
express the type II activated phenotype. In response to stimulation, these macrophages mimic a  
Th2 response, much like the alternatively activated macrophages [6, 184]. 
Response to Exercise 
Changes seen in cytokine production from circulating macrophages in response an acute 
versus chronic exercise may be due to differential macrophage phenotype. Studies have shown 
that chronic resistance and aerobic exercise decrease IFNγ levels in whole blood samples [11, 
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185]. Given that classically activated macrophages require priming by IFNγ for activation, 
exercise may attenuate recruitment and stimulation of classically activated macrophages in 
response to injury. This agrees with the literature that promotes exercise as a therapy for 
decreasing chronic inflammation, as classically activated macrophages promote inflammation in 
a Th1 manner [6]. Furthermore, decreases seen in circulating pro-inflammatory cytokines with 
chronic exercise correlate with the hypothesis that long-term adherence to an exercise training 
program may preferentially stimulate differential macrophage phenotypes within the circulation 
[13]. Conversely, exercise may promote recruitment of the alternatively activated macrophage 
phenotype into the circulation. Exercise has been shown to upregulate IL-4 and increase 
endocrine glucocorticoids, notably cortisol [116, 186]. Both factors are sufficient to stimulate 
the alternatively activated macrophage phenotype, possibly increasing levels of circulating anti-
inflammatory cytokines [187]. 
2.6.3 Macrophage Response to External Inflammatory Stimuli 
Endotoxin, specifically LPS, is the most prevalent stimuli used to induce inflammation 
through activation of the innate immune response in experimental research. LPS is a component 
of gram negative bacteria and acts as an endotoxin to elicit an immune response. LPS is 
composed of three main components; O polysaccharide, core antigen, and lipid A [117]. Lipid 
A exists as a phosphorylated dimer of N-acetylglucosamine plus six or seven fatty acid chains 
that functions as the anchoring region of LPS, conferring the toxicity of LPS to the host [188]. 
The O polysaccharide confers immunogenicity by binding to tissues. It varies largely in 
structure amongst bacterial strains, with polysaccharide chains ranging in length and in structure 
[189]. Once LPS is in the circulation, it promotes inflammation by binding to soluble LPS 
binding protein (LBP) and soluble or CD14 [190]. CD14 delivers the LPS to the recognition site 
of the LPS recognition complex on the plasma membrane of the leukocyte, composed of a toll 
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like receptor (TLR) and lymphocyte antigen 96 (MD2) [191]. When inflammatory stimulus, 
such as LPS, is recognized by macrophages, it causes phagocytosis and degradation of the 
pathogen / pathogen component within the macrophage [192]. Morphological changes as well 
as secretory changes occur, leading to recruitment of neutrophils, immature dendritic cells, NK 
cells, and activated T cells to the site. LPS stimulated macrophages further recruit leukocytes  
by secreting pro-inflammatory cytokines, including IL-1β, IL-6, and TNFα .   
Whereas LPS creates a pro-inflammatory environment through activation of TLRs on 
macrophages, β-ARs are known to be involved in creating an anti-inflammatory response when 
activated on macrophages. Much like MCRs, β-ARs are GPCRs that activate G proteins, 
activating the enzyme adenylate cyclase, resulting in formation of the transcriptional factor 
cAMP. Three subtypes of β-AR have been identified; β1-AR, β2-AR, and β3-AR. All three 
receptor subtypes can lead to activate of the G protein subtype, Gs (stimulatory) and increase 
cAMP. Additionally, the β2-AR can also activate the Gi subtype (inhibitory), inhibiting increases 
in cAMP. β-ARs can be stimulated by several agonists, including the catecholamines Epi and 
NE. Varying β-AR subtypes can be localized to specific tissues throughout the body. Most 
notably, the predominanat β-AR subtype on macrophages is the β2-AR. Catecholamines have 
been shown to play a role in inflammation by inhibiting IL-6, IL-1, and TNFα production from 
mononuclear cells, most likely through β-AR activation [193-194]. In addition, stimulation of 
β2-ARs on whole blood leukocytes have been shown to attenuate LPS induction of TNFα 
production and secretion [42, 195]. Catecholamines also decrease IL-1β secretion in whole blood 
in response to LPS [62]. It is suggested that decreases in pro-inflammatory cytokine production 
in whole blood by LPS stimulation preceded by catecholamine or β-AR agonist is mediated by 
increases in IL-10, as IL-10 increases are seen after catecholamine stimulation [62]. 
Additionally, LPS stimulation of macrophages causes decreases in β2-AR in macrophages [196]. 
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Given the attenuation of inflammation normally associated with LPS treatment of macrophages 
in cultures first stimulated with β-AR agonist, it appears that there may be cross talk between β-
ARs on macrophages and TLRs. It is plausible that the anti-inflammatory effects of exercise are 
partially mediated by elevated catecholamines during exercise, leading to increases in β-AR 
activation on circulating macrophages, that in turn decreases the pro-inflammatory response to 
muscle damage that normally induces activation of the TLRs and production and secretion of 
pro-inflammatory cytokines.  
Response to Exercise 
Exercise creates direct and indirect adaptations of the immune system to inflammatory 
stimuli. Several studies remark on the ability of chronic exercise to alter immunological 
response. In addition to exogenous LPS derived from gram negative bacteria being used as an 
initiator of inflammation in biological studies, endogenous LPS has also been shown to be 
elevated within the circulation of endurance athletes after long races (89.4km) by 81% and these 
changes seemed to correlate with fitness level of the athlete [197]. Additionally, three weeks 
after the race, these same athletes experienced no change in LPS concentration following a 
21.1km run, perhaps due to exercise-induced adaptation of increased IgG binding to circulating 
LPS [197]. Changes in LPS concentration found acutely after exercise coincide with acute 
changes in pro-inflammatory cytokines. Increases in circulating TNFα have been found 
following 2.5h of running [198] and IL-6 immediately after a 10km [197] or 20km run [199].  
Other studies using exogenous LPS stimulation of cultured macrophages from whole 
blood or cultured peripheral whole blood access the effects of exercise conditioning on immune 
response; whether exercise enhances or attenuates the immune response. LPS stimulation has 
been shown to increase TNFα production in peripheral blood cultures following 30 minutes of 
rowing when compared to controls that did not complete a rowing bout [200]. Chronic, moderate 
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intensity endurance exercise training in mice also leads to increased sensitivity to LPS 
stimulation, acutely, with increases in TNFα and IFNγ and concominant decreases in IL-10 (24h 
after exercise and 24h after LPS stimulation) [196]. Conflicting data on the effects of exercise-
induced inflammatory modulations on LPS response in culture do exist. For example, male 
cyclists showed attenuated TNFα increases in response to LPS stimulation after 3 hours of 
cycling [36]. Differences in changes of TNFα seen with LPS stimulation may be due to the 
intensity, duration, or modality of exercise used in the protocol. Also, sampling and assay 
procedure may affect the outcome of the experiments and account for different results. Another 
explanation for differences in results may be due to diet in the experimental groups. For 
example, cyclists were allowed to consume water, tea, or coffee during their experimental trial. 
Because both coffee and tea contain caffeine, and caffeine increases prostaglandin E (PDE), a 
protein responsible for inhibiting the breakdown of the transcriptional factor cAMP, variation 
due to differences in transcriptional regulation of cytokines and differences in catecholamine 
secretion may account for the differences seen between the aforementioned studies.  
Other macrophage plasma receptors also change in response to exercise, independent of  
inflammatory stimuli. For examples, studies show that exercise changes presentation of several 
CD receptors on the plasma membranes of circulating macrophages. Increases in CD64L have 
been found 24h after exercise as well as decreases in CD4 expression at 6 h after exercise, 
indicating a decrease in monocyte activation [201]. CD64L is a cell surface antigen that allows 
monocytes to attach to endothelium. Thus, increases in CD64L may be induced during an 
exercise bout in order infiltrate damaged muscle and help recruit leukocytes to the area to initiate 
repair. CD4 is a cell surface antigen found on T helper cells and monocytes that is used to 
“activate” monocytes and induce inflammation. Thus, downregulation of this receptor may lead 
to changes in inflammatory cytokine production from circulating macrophages / monocytes after 
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exercise. Additionally, CD64 expression, along with CD18 expression, is shown to decrease after 
repeated bouts of exercise [29]. Transient increases in activated macrophages may be an 
indication of enhanced immunity within exercise populations dependent on exercise intensity or 
duration, corresponding to muscular damage initiated during the bout. Thus, concomitant 
decreases in damage during chronic exercise may correlate with decreases in CD receptor 
expression on activated macrophages. 
Although CD receptors are good indices of changes in immunity, recent focus on indirect 
adaptations that may confer alterations with physical activity explore the possibility of TLR2 and 
TLR4 as the mediating key plasma receptors in the model of exercise-induced inflammation. 
TLRs are a six member family of transmembrane receptors possessing an extracellular leucine-
rich repeat (LRR) domain and a cytoplasmic domain [202-204]. TLRs found on several cell 
types, including macrophages, which may explain exercise-induced alterations in immune 
response. TLRs function to recognize pathogens and link the innate immune response to the 
adaptive immune response. Stimulation of the inflammatory response through TLR2 and TLR4 
causes a signaling cascade that promotes inflammation through activation of NF-kB [205-207].  
Activation of TLRs on macrophages ultimately leads to production of TNFα, IL-6, and IL-1β 
[208].  Other adaptations to TLR activation on macrophages include presentation of CD80/86 
and major histocompatibilty complex II (MHC II) on the macrophage plasma membrane, both of 
which allow recognition of the macrophages by other recruited leukocytes in the area [209]. 
Furthermore, production of pro-inflammatory cytokines is directly correlated with TLR4 
expression on macrophages [210]. TLRs may retain the ability to control inflammation in 
response to exercise, whereby TLR activation on macrophages due to exercise leads to the 
production and secretion of pro-inflammatory cytokines into the circulation. A viable 
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explanation whereby repeated bouts of exercise decreases chronic inflammation may be due to 
changes in cell surface expression of TLRs on systemic macrophages. 
Several studies support this hypothesis of exercise-induced changes in the pro-
inflammatory receptor, TLR, and inflammation. Prolonged aerobic exercise in the form of 
cycling (two and half hours at 60% Vo2 max) has been shown to decrease cell surface expression 
of TLRs on macrophages [209, 211]. Furthermore, decreases in TLR2 and TLR4 with exercise 
training coincide with decreases in IL-6 production and MHC II and CD80/86 presentation 
[211]. Other studies utilizing resistance training have confounding conclusions. In a cross 
sectional study, resistance trained elderly women showed significantly decreased in TLR4 
mRNA in conjunction with decreased production of IL-6, IL-1β, and TNFα after LPS stimulation 
of whole blood cultures when compared to sedentary controls [212]. Yet, in a separate training 
study, when blood is taken immediately post exercise, TLR4 is significantly increased compared 
to the control group resting sample but is not different from the exercise trained resting sample 
[212]. In the same study, however, resting blood levels of TLR4 decreased in exercise-trained 
individuals compared to untrained control individuals. Furthermore, no changes were seen in 
TLR4 following a twelve week resistance and endurance training intervention when compared to 
baseline TLR4 values as well as resting control TLR4 values [22]. Conversely, TLR4 has been 
shown to decrease in response to a combined endurance and resistance exercise training regimen 
[38]. Limitations to the present body of data on exercise-induced changes in TLR expression 
include the training regimen and blood sampling time, which may explain the differences seen in 
TLR expression in response to training.  
2.6.4 Influence of Exercise Mode, Intensity, and Duration on Macrophage Function 
In all exercise based studies, it is important to note the differences and similarities in 
exercise mode, intensity, and duration used as treatment. Mode, intensity, and duration all play a 
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role in determining activation of differential metabolic systems during an exercise bout; 
oxidative phosphorylation or glycolytic respiration [213-214]. Oxidative phosphorylation 
involves the metabolism of glucose, either plasma glucose / glycogen derived glucose or beta 
oxidation of free fatty acids (FFA), by type I oxidative muscle fibers or type IIa intermediate 
muscle fibers. Utilization of either glucose of FFA is further dependent on the duration of the 
exercise bout [213]. Glucose is first utilized during low intensity bouts, followed by oxidation of 
FFA during longer duration low intensity exercise bouts. Both fuel sources require the presence 
of oxygen within the mycocyte mitochondria as the final electron acceptor.  
Several factors influence the rate at which aerobic versus anaerobic respiration take 
place. Perhaps foremost oxygen delivery and utilization by myocyte mitochondria determines the 
type of respiration [215]. Upon inspiration oxygen crosses from the aveoli within the lungs to 
surrounding capillaries where it binds hemoglobin within the red blood cells (RBC) [216] 
Oxygenated blood then flows from the lungs to the left atrium then the left ventricle and out to 
the systemic circulation. During exercise, blood flow is redistributed from the splanchnic organs 
to working muscles where formation of ATP is critical for continued muscle contraction [217]. 
Increased amounts of oxygenated blood are delivered to the myocyte. Once at the myocyte, 
oxygen dissociates from hemoglobin, crosses the sarcolemma, and binds to high affinity 
myoglobin within the muscle cells. Myoglobin works to deliver the oxygen from the outside of 
the myocyte to the mitochondria [218]. At the mitochondria, oxygen can be used as the final 
electron acceptor for hydrogen ions formed from oxidation of NADH and FADH in the electron 
transport chain, ultimately forming water. The ability of aerobic respiration to take place is 
dependent on fuel availability, mitochondrial content, mitochondrial enzyme function, 
hemoglobin content, RBC count, myoglobin content, and fuel source. Conversely, anaerobic 
respiration utilizes plasma glucose or glycogen derived glucose or phosphocreatine, without the 
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presence of oxygen, as possible fuel sources for ATP formation and, thus, is not dependent on 
mitochondrial number or function, hemoglobin, myoglobin, or RBC count. Instead, anaerobic 
respiration is dependent on fuel availability and enzyme activity.  
Additionally, oxidative versus glycolytic forms of respiration are dependent on 
differential recruitment of muscle fiber type.  There are two general phenotypes of recognized 
muscle fibers; type I and type II fibers. Type I fibers are distinctive under a light microscope by 
their dark coloration, due to high amounts of myoglobin within the fibers. Type I fibers possess 
large amounts of mitochondria and are innervated by small diameter alpha motor neurons, 
causing a slower transmission of electrical signals from the spinal cord needed to depolarize the 
myocyte. Thus, type I fibers are considered slow twitch fiber types that utilize forms of oxidative 
phosphorylation [219]. Muscle groups compromised of mostly red fibers are mostly type I fibers 
and generate less power and velocity of shortening yet can sustain cycling contraction / 
relaxation for long durations [32]. Type II fibers are lighter in color than type I fibers, indicating 
less mygoblin content. These fibers also contain less mitochondria than type I fibers and are 
innervated by larger diameter alpha motor neurons, allowing faster transmission of electrical 
signals from the spinal cord [219]. Type II fibers can be further subcategorized based on the type 
of myosin ATPase present in the fiber. Type IIa fibers are generally referred to as intermediate 
fibers, as they have characteristics found in type I fibers. Type IIa fibers can use either aerobic or 
anaerobic pathways for ATP formation. Type IIx fibers are generally referred to as fast 
glycolytic fibers, as they are used during high intensity physical activity of short duration [219]. 
Muscle groups composed of white fibers are mostly type II fibers that can generate large power 
output and a faster velocity of shortening but can only sustain cycling contraction / relaxation for 
short periods of time. In addition some muscles are mixed muscles, meaning they contain both 
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red and white fibers and can perform either low power long duration or high power short 
duration exercises [32].  
Due to differential recruitment of fiber phenotype with exercise modality, intensity, and 
duration, there are differential by-products and end products. With both aerobic and anaerobic 
exercise, by-products include hydrogen ions from the intermediate reactions of glycolysis, lactate 
from pyruvate if there is little oxygen present, and conversion of lactate into lactic acid [220-
222]. Consequently, anaerobic respiration will cause formation of elevated levels of lactate and 
lactic acid in the circulation in comparison to aerobic respiration. It is important to take these by-
products into consideration when evaluating the immune response to exercise, as several 
researchers have noted that they contribute to decreases in blood and muscle pH, with larger 
decreases seen in muscle pH. When pH is decreased below optimal levels, respiration will be 
unable to continue due to dysfunctional enzymes, and exercise performance decreases [222]. It is 
also plausible that formation of varying amounts of by-products may cause differences in the 
circulating inflammatory profile and cytokine production. In fact, a positive direct correlation 
exists between lactate levels and the anti-inflammatory cytokine, IL6, in young male wrestlers 
[27]. 
Because various muscle groups are innately different from each other, it follows that 
recruitment of differing fiber types as well as the amount of fibers or motor units recruited during 
an exercise bout may play a role in differences seen in exercise-induced inflammation. Evidence 
suggests that changes in systemic leukocyte number may be due to muscle recruitment, where 
recruitment of larger muscle groups during an exercise bout leads to larger numbers of 
circulating leukocytes afterwards and vice versa [29]. Researchers believe that the initial increase 
in circulating pro-inflammatory cytokines is due to damage of the muscle during an exercise 
bout. It seems plausible that contraction of large muscle groups and recruitment of more motor 
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units during an exercise bout may potentially lead to increased damage and inflammation.  A 
positive correlation exists between leukocyte number after acute exercise and degree of soreness, 
a possible measurement of muscle damage [201].  
Another possible explanation for inflammatory differences associated with muscle size 
may be due to the ability of larger muscle groups to increase core body temperature more 
effectively than small muscle groups. Increases in body temperature increase activation of heat 
shock proteins. Heat shock proteins in turn have been implicated in promoting a pro-
inflammatory state, in conjunction with pro-inflammatory cytokines [13]. For example, heat  
shock protein 70 (HSP70) has been shown to increase acutely after an intense endurance exercise  
Ironman triathlon) bout involving whole body muscular contraction, especially large muscle  
groups such as the quadriceps and hamstrings [24]. 
As previously stated, modality, intensity, and duration may all affect the peripheral 
changes seen in circulating cytokines as well as leukocytes. Studies show high intensity exercise 
(≥ 75% VO2max) leads to secretion of IL-6 more so than moderate or low intensity exercise 
[14]. A positive correlation exists between leukocyte number after acute exercise and exercise 
intensity and soreness [201, 223-224].  Researchers have found that short duration, low to 
moderate intensity exercise is not without inflammatory benefits. Five or fifteen minutes of low 
or moderate aerobic exercise in mice both lead to increases in the number of total leukocytes and 
peritoneal macrophages as well as an increase in the phagocytic activity of the macrophages 
[225]. Other increases in macrophage phagocytic activity have been noted after an acute bout of 
endurance exercise (one hour of swimming) in rats and mice (thirty, sixty, and one hundred 
twenty minutes of treadmill running) [35, 226]. In addition, peritoneal macrophage phagocytosis 
has been shown to significantly increase in response to anaerobic exercise (plyometrics, 48h after 
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exercise) in rats that have been immunocompromised by injection with tumor inducing cells 
[227]. 
In addition to leukocyte recruitment and differential activation of macrophages as well as 
increased phagocytic activity of macrophages associated with exercise, mode, intensity, duration, 
and muscle group contraction also affect cytokine production. Studies show that several 
modalities of exercise (cycling, running, eccentric, and knee extensor exercises) all significantly 
increase levels of IL-6 acutely [181].  Other studies report that eccentric elbow flexion in young 
(20-22 years), untrained male individuals leads to no changes in IL-6; although, the protocol for 
the eccentric elbow flexion did not mention how much weight was lifted by participants and how 
this related to the intensity of the eccentric bout. Furthermore, the exercise session only included 
eccentric elbow flexion, 5 sets of 6 reps with 2 minutes of rest in between sets [17]. It appears 
that perhaps intensity may play a larger role in exercise-induced inflammation than modality. For 
instance, changes seen in IL-6 and IL-1 acutely after eccentric exercise directly vary with 
intensity of the eccentric exercise, where changes are seen with moderate intensity eccentric 
exercise but larger increases are seen with high intensity (≥ 75% VO2max) eccentric exercise 
[29]. Changes in other pro-inflammatory cytokines also appear to be dependent on exercise 
intensity. TNFα  has been shown to significantly increase acutely after a moderate shuttle walk 
test, and this increase was magnified using a higher intensity strenuous shuttle walk test in the 
same group [228]. After one month of daily training in these same participants, TNFα decreased 
after an acute shuttle walk test. Exercise intensity plays a large role in determining inflammatory 
response to exercise, and exercise training leads to adaptations in response to repeated acute 
upregulation of pro-inflammatory cytokines that may desensitize leukocytes to these cytokines. 
Conversely, there may be no desensitization, but rather sensitization of leukocytes to pro-
inflammatory cytokines with chronic exercise, leading to a sensitization of anti-inflammatory 
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pathways and a faster or more efficient response of the anti-inflammatory pathways to stimulus, 
eventually causing the decreases in TNFα and other pro-inflammatory cytokines seen acutely 
after an exercise bout in trained individuals.  
Other evidence exists to support the role of exercise intensity and duration in regulating 
the immune response. After an intense Ironman triathlon, IL-6 and IL-10 were elevated acutely 
(thirty minutes post exercise) and returned to baseline levels within one day [24]. Marathon 
racers also experience increases in IL-6, IL-10, TNFα, and Il-1β acutely after a race [29]. 
Furthermore, IL-6, TNFα, and IL-1β are acutely elevated when a combination of intense aerobic 
and anaerobic wrestling bout is performed in young male wrestlers [27].  
2.6.5 Age May Influence Inflammatory Responses to Exercise 
In addition to intensity, duration, and modality, evidence is suggestive of a role of muscle 
fiber type and size in inducing inflammation acutely after an exercise bout. It follows that age of 
participants may also affect the inflammatory response to exercise. With age, atrophy of muscle 
occurs, decreasing strength and mass of the muscle. Additionally, changes in fiber type occur 
with aging. Over time the predominant muscle fiber type becomes type I, slow twitch oxidative 
fibers in elderly individuals. The change in muscle fiber type and increases in atrophy lead to 
reduced velocity of shortening of the muscle during contraction and decreases in force 
development and, consequently, power output [29].  Studies show that changes in leukocytosis 
also occur with aging. Elderly males have exhibited attenuated response of neutrophils in the 
systemic circulation, with 20% less recruitment when compared to young males [29]. Changes in 
systemic cytokines in response to exercise have also been reported to be dependent on age. IL-6 
production and secretion after downhill running in elderly males is only equal to 90% of the IL-6 
produced and secreted during the same exercise bout in young males [29]. In addition, IL-6, 
TNFα, IL-1β, and IL-10 exhibit attenuated elevation in response to LPS stimulation of 
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macrophages in aged mice when compared to younger mice [229-230]. Although changes in 
circulating cytokine production have been seen in response to exercise and LPS stimulation in 
humans and mice, respectively, the mechanism for these changes in unclear and little research 
has explored the mechanism behind the differences associated with aging. It does appear, 
however, that the changes seen with age may not involve changes in receptor expression on 
macrophages. Studies show no significant changes in TLR expression in young versus older 
humans, although aged mice do exhibit decreased amounts of TLR4 when compared to younger 
mice [18, 230-232]. 
2.7 Literature Review Summary 
Extensive research has been conducted on changes in pro- and anti-inflammatory 
cytokines in response to exercise bouts and training. Several representative studies have been 
reported here in order to demonstrate the changes seen acutely and chronically after exercise. All 
agree that exercise induces secretion of acute phase reactants into the systemic circulation, 
promoting inflammation, and that chronic phase reactants are found in the systemic circulation in 
response to long term exercise training. Where these studies differ is in the explanation of where 
and how these circulating cytokines are secreted. While several studies propose that pro-
inflammatory cytokines are secreted from circulating leukocytes acutely after exercise, others 
express the conclusion that pro-inflammatory cytokines are produced from myocytes in response 
to muscle damage caused by the bout itself. Whether pro-inflammatory cytokines are secreted by 
circulating leukocytes or myocytes remains an area of debate, while a consensus exists amongst 
researchers regard to the source of production and secretion of anti-inflammatory cytokines in 
response to chronic exercise. Researchers agree that the presence of pro-inflammatory cytokines 
seen acutely after exercise lead to concomitant increases in anti-inflammatory cytokines from 
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circulating leukocytes. These adaptations to chronic exercise help to explain the beneficial 
effects of exercise training in diseased populations that exhibit low grade chronic inflammation. 
While it is agreed that exercise training leads to beneficial adaptations within the 
inflammatory response, the mechanism behind these exercise-induced changes in systemic 
cytokine profile remains unclear. It is most likely, given the redundancy of the biological system, 
that several adaptations to exercise training culminate to create a reduction in chronic 
inflammation. Changes in immune cell response are affected by several different mechanisms. It 
is possible for one researcher to illuminate these changes due to the magnitude of the task. First, 
there are several subpopulations of leukocytes to take into account in affecting inflammation. 
Second, subpopulations are derived from different tissues in response to different signals. Third, 
different types of stimuli on the immune system cause differential expression of populations of 
immune cells. Furthermore, within subpopulations, there is differential phenotype expression of 
immune cells.  Fourth, populations exhibit various expression patterns of recognition receptors in 
response to varying stimuli. Activation of different receptors leads to differing downstream gene 
and protein expression patterns. Additionally, various receptors, either on the same cell or other 
immune cells, may communicate through cross-talk, complicating pathway activation or 
repression in order to regulation gene and protein expression. Although a consensus is seen in the 
end product of exercise training on inflammation, elucidating the mechanisms behind these 
changes remains a daunting task.  
I have concentrated this review and my studies on the immune response of monocytes 
and macrophages to exercise, acutely and chronically. Several mechanisms for changes in 
inflammatory cytokine secretion from macrophages have been proposed and studied. Most 
notably, differential expression of the β-ARs and TLRs have been researched as effectors of 
exercise-induced changes in inflammation. Each class of receptor seems to play a crucial and 
                                     
50 
opposite role in mediating cytokine production in macrophages. TLR2 and TLR4 induce 
inflammation by causing upregulation of pro-inflammatory cytokine production; whereas, β-ARs 
are noted to cause upregulation of anti-inflammatory cytokines. β-ARs and TLRs respond to 
different stimuli. β-ARs respond to catecholamines, Epi and NE, while TLRs respond to LPS and 
other endotoxin pathogens. It appears that induction of the pro-inflammatory response is due to 
damage of myocytes during an exercise bout, and induction of the anti-inflammatory response is 
due to changes in endocrine hormone circulation during and after an exercise bout.  Although, 
the β-ARs and TLRs appear to regulate exercise-induced changes in inflammation, studies of 
changes in receptor expression in response to exercise remain controversial.  
Few other macrophage plasma receptors have been extensively studied in response to 
exercise. It is known that macrophages, integral in the response to stress and initiators of the 
immune response, possess MCRs. MC3Rs are important in regulation of metabolic responses, 
such as nutrient partitioning, in the hypothalamus within the CNS, where they are activated by 
various derivatives of the propeptide POMC, including ACTH, α-MSH, β-MSH, and γ-MSH.  
In addition to the potential role of the MC3R in the CNS in regulating nutrient 
partitioning, recent investigations have concentrated on MC3R expression in peripheral tissues. 
One additional role of MC3R may be its ability to regulate circadian rhythms through integration 
with the food entrainable oscillator. Another function of MC3R in the periphery focuses on its 
expression on macrophages. Studies have shown that activation of the POMC neurons occurs 
during inflammation in response to pro-inflammatory cytokines; IL-6, IL-1β, and TNFα. This 
translates to increased ACTH secretion in the hypothalamus. Studies also show that circulating 
POMC and ACTH levels are increased during inflammation in the periphery. MC3Rs have been 
shown to play a role in cytokine production from macrophages in response to stress. Activation 
of the MC1R and MC3R causes macrophages to secrete IL-10, an anti-inflammatory cytokine, 
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which in turn inhibits secretion of IL-6, IL-1β, and TNFα from leukocytes. It appears that the 
MC3R may function in a comparable manner within the periphery as within the CNS, where the 
melanocortin system is expressed in both locations, but different outcomes are present in 
response to MC3R activation. In peripheral tissues, MC3R may function to regulate 
inflammation through its expression on systemic macrophages. The immunomodulatory role of 
the MC3R on monocytes may further be amplified by activation of the MC1R. Furthermore, 
MC1R and MC3R expression may be affected by exercise and activation seems a plausible 
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 Exercise training has been shown to create favorable changes in inflammatory profiles. 
Specifically, resistance training has been shown to dowregulate systemic pro-inflammatory 
cytokines associated with chronic inflammation and upregulate anti-inflammatory cytokines [39, 
174-175]. It has been established that exercise training results in chronic downregulation of 
inflammatory cytokine production and secretion within circulating monocyte populations via 
downregulation of the toll-like receptors [205-208]. Whereas regulatory pro-inflammatory 
receptors have been identified on monocytes, few studies have examined possible anti-
inflammatory receptors that may regulate changes in anti-inflammatory pathways associated with 
chronic exercise training. The MC3R is a member of five GPCRs that make up the melanocortin 
receptor family, MC1R through MC5R. MC3R is known to increase secretion of the anti-
inflammatory cytokine, IL-10, from cultured macrophages [71, 74]. Additionally, activation of 
MC3R with agonist leads to downregulation of the pro-inflammatory cytokines, IL-6 and TNFα, 
from cultured macrophages in response to inflammatory stimuli, likely due to upregulation of IL-
10 [74-75]. In addition to MC3R, monocytes as well as several other immune cell populations 
have been shown to express MC1R and MC5R [67, 82]. Whereas MC5R has not been shown to 
be critical in regulating cytokine expression and secretion from monocytes and macrophages, 
MC1R and MC3R have both been shown to have redundant modulatory roles within monocyte 
and macrophages cell lines [69-70]. 
Although multiple lines of evidence suggest that MC3R plays an immunomodulatory role 
through regulation of gene expression in macrophage cell lines, to our knowledge, no studies 
have explored the effects of exercise training on monocyte MC3R expression. I recently found 
that MC3R mRNA expression increased 13-fold in whole blood samples taken after a 12 week 
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resistance training intervention. Thus, my current efforts have been focused on determining 
whether changes in MC3R mRNA translate to changes in MC3R protein expression on the 
plasma membrane of systemic monocytes. 
 In the present study, I examined the modulation of MC1R and MC3R expression in 
response to resistance training in young, healthy adults. My results clearly demonstrate that 
resistance training increases the number of monocytes expressing MC1R but decreases the 
number expressing MC3R. In addition, I show that MC1R and MC3R receptor density on 
monocytes decreases in response to resistance training. I also show that changes in MC3R but 
not MC1R expression negatively correlates to changes in body composition. Resistance training 
also leads to changes in the inflammatory profile, evidenced by decreases in CRP and transient 
upregulation of IL-6 and chronic decreases in IL-10 protein expression.  
3.2 Materials and Methods 
3.2.1 Participants and Screening  
Thirty-nine healthy, physically active college-aged students were recruited for this study. 
The resistance training group (n = 23) consisted of interested males and females from a senior 
level Kinesiology course (KIN 4501-The Physiology of Strength Training) at Louisiana State 
University. Students learned advanced techniques in strength training and completed the below 
measurements as part of the class. Students interested in the training group portion of this study 
were asked if they were interested in allowing us to use data collected in the class for research 
purposes. Students were not penalized for not participating in the study. An “active control” 
group (n = 19) consisted of active males and females who participated in an endurance or 
resistance training program on a regular basis. The active control group participants were 
recruited by word of mouth. This project was approved by the LSU Intuitional Review Board.  
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3.2.2 Preliminary Testing  
Medical Screening, Health History and Physical Activity Questionnaires 
Subjects in the training group received permission to participate from a State licensed 
M.D. All study participants (training and active control) completed a medical history form. 
Additionally, all participants filled out the International Physical Activity Questionnaire (IPAQ)-
Short Format [233]. The IPAQ-short format is an instrument that can be used to obtain 
internationally comparable estimates of physical activity with adults aged 18-65 yr. It is designed 
to assess health-related aspects of physical activity and sedentary behaviors. The short version 
contains 4 items (7 questions) targeting time spent in vigorous- and moderate-intensity activity, 
walking, and in sedentary activity. The screening and questionnaires were designed specifically 
with the participant’s health in mind by: 1) preventing those with pre-existing conditions from 
participating in a running program/study and 2) allowing the researchers to become aware of any 
potential health issues.   
3.2.3 Baseline Resting Measurements 
Baseline measurements in both training and control groups were taken in the Exercise 
Physiology Laboratory at Louisiana State University (LSU). Subjects were instructed to refrain 
from exercising on the day of testing. Upon arrival, the subjects were given the Informed 
Consent form and given time to review the document. Then, the investigator explained the 
experimental protocol and answered any questions.  
Body Composition 
Body density was assessed using Dual X-ray Absorptiometry (DXA) in the Nutrition and  
Health Assement Laboratory in the School of Human Ecology at LSU. Subject age, gender, 
ethnicity, and height and weight were entered into the DXA apparatus (Prodigy Pro, GE Lunar 
Medical Systems, Madison, WI). Participants were then asked to remove all of their jewelry and 
metal objects and lie on their back on the DXA table. T
duration of the scan, about 5 minutes or less. All measurements were taken by a trained DXA 
operator (Tara M. Henagan).  
Resting Metabolic Rate (RMR) 
Subjects underwent a test for resting metabolic rate (RMR) at the begin
training intervention (or normal activity in active control) (PRE) and end (POST) of the 12
experimental period.  RMR was obtained while subjects rested quietly for 30 minutes and 
breathed into a mouthpiece so that expired air was collecte
consumption, carbon dioxide production and total ventilation
Blood Sampling 
Participants were asked to report to the lab aft
exercise from the previous 72 hours between 0800
before the baseline, pre-training blood sample were obtained 
blood was obtained by a registered nurse
EDTA (BD-Pharmingen, USA). At the end of the twelve week training per
collected again POST from both the active control and trained group 72 hours after
resistance training bout. 
FIGURE 1. Study Timeline 
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3.2.4 Acclimation and Training  
Acclimation  
Both the active control and training groups completed a 2 week-long acclimation period 
to the following resistance exercises: bench press, bent over rows, shoulder press, barbell curls, 
dumbell shrugs, tricep pressdowns, crunches, squat, deadlift, walking lunges, lying leg curl, leg 
extension, and standing and seated calve raises. They performed four acclimation exercise 
sessions on non-consecutive days (Monday and Wednesday or Wednesday and Friday). On 
acclimation day 1 (ACC 1), participants were taught proper lifting techniques for each of the 
seven upper body exercies to minimize the risk of injury. Each subject in the control and trained 
groups performed one set of 10-15 repetitions of bench press, bent over rows, barbell curls, 
dumbell shrugs, tricep pressdowns, and crunches. On the second acclimation day (ACC2), 
participants were taught proper lifting techniques for each of the seven lower body exercies to 
minimize the risk of injury. Participants then performed one set of 10-15 repetitions of each 
exercise; squat, deadlift, walking lunges, lying leg curl, leg extension, and standing and seated 
calve raises. On the third acclimation day (ACC3), participants performed the same exercises as 
ACC1 but performed two sets of each at 10-15 repetitions. One the fourth acclimation day 
(ACC4), participants performed the same exercises as ACC2 but performed  two sets of each at 
10-15 repetitions. 8-RM for bench press, squat, and deadlift exercises was assessed on ACC3 
and ACC4. All acclimation and exercise sessions were preceded by 5-10 min of cycle ergometry 
or walking. All acclimation sessions and resistance exercise sessions were completed in the 
Stadium Weight Room or University Recreational Center at LSU under the supervision of 
trained technicians. (See Figure 1.) 
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8 RM testing 
 Following the acclimation period but before the intervention period and following the 
intervention period, CON and RT individuals underwent 8RM testing for bench press and squat. 
Subjects were asked to perform one set of 10 – 12 repetitions of lift weight as a warm up set. 
Subjects then rested for 2-3 mins. Based on the individuals assessment, a suitable weight was 
determined in the use of the 8RM testing. The subject was asked to perform 8 repetitions, 
coming to complete muscle failure by the eighth repetition. If the subject could not complete 8 
repetitions or completed more than 8 repetitions at the current weight, the weight was increased 
or decreased by 5-10% accordingly. The subject was then asked to perform the lift again with the 
goal being complete muscle failure by the eighth repetition. The subject rested 2-3 mins between 
tries if the 8RM was not reached on the first try. The subject was allowed 3 tries to reach the 
8RM for a specific lift. Upon competion of the 8RM, the weight was recorded for each subject. If 
the subject did not reach the 8RM by the third try, the weight lifted and the number of repetitions 
was recorded. The 8RM was then determined using the CSCS calculation for RM testing. 
Training 
Following the acclimation and testing period, the training group completed 12 weeks of 
progressive resistance training on non-consecutive days (3x / week) and were asked to maintain 
their normal diet.  Subjects in the training group were provided with a training routine to follow. 
The training was periodized and progressive (Appendix 1).  Progression was implemented by 
asking participants to complete a given repetition range for a specified number of sets for each 
lift until failure. If the participant was able to complete and repetitions for all sets of a given lift 
without reaching failure, the load was increased during the following training period until failure 
was reached. Participants were supervised to ensure proper lifting techniques for each of the 
exercise to minimize the risk of injury and proper progression through the training plan.  The 
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active control group did not undergo supervised exercise sessions, but were asked to maintain 
their normal activity and eating habits. 
3.2.5 Post Intervention Data Collection  
Post intervention measures were performed on all participants following the 12 week 
intervention. Procedures for post-training measurements were identical to the protocol followed 
for the baseline resting and exercise measures outlined above.   
3.2.6 Blood Analyses 
Flow Cytometry 
EDTA-treated blood was incubated with either MC1R (Santa Cruz) or MC3R (Amolone) 
or CD14 (eBioscience) antibody as well as a three-color isotope control. The percent variation in 
MC3R over a 3 day time period was 7.35% (P = 0.89) for the percentage of monocytes 
expressing MC3R and 0.50% (P = 0.94) for MC3R MFI. Primary gates were established on 
leukocyte populations using forward and side scatter light; secondary gating was established 
using CD14 to identify and analyze monocyte populations. All experiments were performed 
using the FACS Laboratory at the LSU School of Veterinary Medicine.  
Serum Cytokine Profiles  
Plasma was collected from EDTA-treated whole blood samples by centrifugation (14000 
rpm, 4°C, 10 minutes) immediately following blood collection and was used in commercially 
available ELISA kits to measure amounts of CRP (ALPCO) and circulating cytokines IL-6 
(eBioscience) and IL-10 (eBioscience). Intra-assay coefficients of variation were 6%, 4.9%, and 
6.8% Inter-assay coefficients were 13.8%, 6.0%, and 7.5% for CRP, IL-6 and IL-10 respectively.   
3.2.7 Statistical Procedures 
The two-tailed Student t-test, linear regression, and a 2 (PRE vs. POST) X 2 (CON vs. 
RT) repeated measures analysis of variance (ANOVA) were used for determining the 
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significance of the experimental differences when appropriate. Significance was set at P < 0.05. 
Bonferroni post hoc tests were used when appropriate. All statistical analyses were performed 
using GraphPad Prism or JMP statistical software. Correlations were determined using linear 
regression analysis in GraphPad Prism software. All values reported are means ± SEM.  
3.3 Results 
Nineteen subjects were enrolled in the CON group and twenty-three subjects were in the 
RT group, two CON subjects dropped out over the course of the 12 week intervention period and 
all RT participants completed the study. Even though this study was not designed to determine a 
gender effect, relatively equal numbers of men and women were used in this study. The CON 
and EX group consisted of 7, 12 and 11, 12 male and female participants, respectively.   
Age, height, and body weight (BW) variables were not different at baseline in CON and 
RT and remained unchanged and not significantly different POST. Age ranged from 20 to 27 yr 
in the CON group and from 18 to 27 yr in the RT group. Height ranged from 152.2 to 190.5 cm 
in the CON group and from 156.2 to 184.7 cm in the RT group (TABLE 1). BW ranged from 
47.17 to 136.08 kg in the CON group and from 53.43 to 158.3 kg in the RT group before the 
intervention and did not change in both groups after the intervention period (TABLE 1). BMI 
ranged from 19.85 to 37.5 kg/m
2
 in CON and from 19.78 to 45.42 kg/m
2
 in RT prior to the 
intervention period and did not change significantly in either CON or RT after the intervention 
period (TABLE 1).  
There were no differences in lean body mass (LBM) percentage or LBM or body fat 
percentage between CON and RT groups at baseline (FIGURES 2 and 3 and 6), however 
participants in the RT group significantly increased LBM by 1.15 ± 0.27 kg (POST – PRE), a 
1.84 ± 0.46% increase (FIGURES 4 and 5). This increase was significantly larger than the 
change in LBM seen in CON (0.29 ± 0.28 kg, POST – PRE), a 0.63 ± 0.34% change (FIGURES 
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4 and 5). Furthermore, the change in body fat percentage was significantly different in RT, who 
had a 1.55 ± 0.45% decrease in body fat percentage (POST – PRE), and CON, who had a 0.54 ± 
0.35% decrease in body fat percentage (POST – PRE, FIGURE 7). There were no significant 
changes in bone mineral content (BMC) PRE or POST in CON (2.74 ± 0.17 kg PRE vs. 2.48 ± 
0.17 kg POST) and RT (2.98 ± 0.13 kg PRE vs. 2.97 ± 0.12 kg POST). There were no significant 
differences in RMR or RER in either CON or RT (TABLE 2).  
TABLE 1. Descriptive data for subjects. 
Descriptive data for the subjects before (Pre) and after (Post) the 12-week resistance training 
intervention. CON, active control group; RT, resistance training group.  
* denotes significant differences between CON and RT groups. 
 
Variable  Time  
CON  RT 
(n=18) (n=22) 
Age   21.4 ± 0.42 22.2 ± 0.38 
Height (cm)   166.32 ± 2.14 171.85 ± 1.94 
Body Weight (kg) Pre 68.12 ± 4.98 75.49 ± 4.61 
  Post 67.76 ± 4.88 74.84 ± 4.41 
BMI (kg/m
2
) Pre 24.18 ± 1.19 24.23 ± 1.04 
  Post 24.07 ± 1.10 24.06 ± 0.99 
8RM Test (% change) Bench Press 
-11.44 ±  4.04 
(n=7) 
5.58 ± 3.01* 
(n=15) 
  Squat 
-5.18 ±  4.28 
(n=6) 
11.82 ± 3.02* 
(n=14) 
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3.3.1 Training Program Results 
Compliance was recorded weekly through self recorded workout logs All exercise 
participants completed 92% of the prescribed exercise sessions. The RT group experienced 
significant increases in 8RM in both bench press and squat and the percent change in strength 
was significantly greater in RT compared to CON after the intervention period. The RT 
experienced 5.58% ± 3.01 (143.05 ± 17.92 PRE vs. 156.75 ± 18.58 POST) and 11.82% ± 3.02 
(170.83 ± 15.93 PRE vs. 193.11 ± 19.29 POST) increases in the bench press and squat 
respectively (TABLE 1). The amount of work performed each week by the RT group varied, as 
an undulating periodized routine was utilized over the twelve week period. The lowest work 
completed was during weeks 3 and 9 and the highest at weeks 7 and 8. The number of repetitions 
recommended ranged throughout the 12 week intervention from 442 repetitions per week to 



























FIGURE 2.  LBM percentage. 
Lean body mass (LBM) percentage before (PRE) and after (POST) the intervention period. 
CON, active control group; RT, resistance training group. There were no significant differences 
in LBM percentage in RT or CON PRE to POST. 





















FIGURE 3. LBM. 
Lean body mass (LBM) before (PRE) and after (POST) the intervention period. CON, active 
control group; RT, resistance training group. There was a significant interaction between time 





















































FIGURE 4.  Change in LBM percentage (POST – PRE). 
CON, active control group; RT, resistance training group. The change in lean body mass (LBM) 
percentage (POST – PRE) was significantly larger in the RT vs. the CON group (P < 0.05 by t 
test). *denotes significant difference between CON and RT groups 







































FIGURE 5.  Change in LBM (POST – PRE). 
CON, active control group; RT, resistance training group. The change in lean body mass (LBM; 
POST – P5E) was significantly larger in the RT vs. the CON group (P < 0.05 by t test). *denotes 






























FIGURE 6. Body fat percentage. 
Body fat percentage before (PRE) and after (POST) the intervention period. CON, active control 
group; RT, resistance training group. There were no significant differences in body fat 
percentage in RT or CON.  
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FIGURE 7. Change in body fat percentage (POST – PRE). 
Change in body fat percentage (POST – PRE). CON, active control group; RT, resistance 
training group. Decreases in body fat percentage were significantly large in RT than CON. (P < 
0.05 by Students t test). *denotes significant difference between CON and RT groups. 
 
TABLE 2. RMR and RER. 
Resting metabolic rate (RMR) and respiratory exchange ratio (RER) before (Pre) and after (Post) 
the intervention period. Values are means ± SEM. CON, active control group; RT, resistance 
training group 
 
Variable  Time  CON (n=19) RT (n=22) 
RMR (kcal / day) Pre 1915.64 ± 117.91  2045.36 ± 106.88 
  Post 1839.15 ± 76.94  2106.19 ± 110.29  
RER Pre 0.80 ± 0.02 0.81 ± 0.01 
  Post 0.79 ± 0.01  0.83 ± 0.01  
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3.3.2 Monocyte Cell Surface Expression of MC1R and MC3R 
Prior to the intervention, there were no significant differences between CON and RT in 
the percentage of monocytes expressing MC1R (82.16 ± 1.89% in CON vs. 84.11 ± 1.16% in 
RT) or MC3R (7.75 ± 1.52% in CON vs. 12.33 ± 2.25% in RT; FIGURES 8 and 9). The 
percentage of systemic monocytes expressing MC1R significantly increased from 84.11 ± 1.16% 
to 91.41 ± 0.79 % in response to RT whereas the percentage of monocytes expressing MC1R in 
the CON group did not change (82.16 ± 1.89% PRE vs. 83.36 ± 1.93% POST; FIGURE 8). The 
percentage of monocytes expressing MC3R significantly decreased in RT (12.33 ± 2.25% PRE 
vs. 6.47 ± 0.84% POST) with no change in CON (7.75 ± 1.52% PRE vs. 6.58 ± 1.3% POST), 
although there was a significant effect of time (FIGURE 9). No differences in the amount of 
MC1R and MC3R receptor density, determined by the mean fluorescence intensity (MFI), were 





































FIGURE 8. Percentage (%) of systemic monocytes expressing melanocortin 1 receptor 
(MC1R) protein on the cell surface. 
Pre, before intervention; Post, after intervention. CON, active control group; RT, resistance 
training group. The percentage of monocytes expressing MC1R protein increased in RT but not 
CON after the intervention period (P < 0.001 by two way ANOVA). *denotes significant 
difference between Pre and Post values within CON or RT groups 
 










































FIGURE 9. Percentage (%) of systemic monocytes expressing melanocortin 3 receptor 
(MC3R) on the cell surface.  
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group. The percentage of monocytes expressing MC3R protein 
decreased in response to RT, and there was a significant effect of time in the model (P < 0.05 by 
two way ANOVA). *denotes significant effect of time; Ψ denotes significant effect of treatment  
 
At the POST time point, the amount of MC1R expressed on individual monocytes or the 
MC1R MFI significantly decreased from 33.82 ± 2.31 PRE to 15.05 ± 0.92 POST in RT with no 
change in MC1R MFI in CON (32.75 ± 2.33 PRE vs. 27.85 ± 2.94 POST; FIGURE 10). MC3R 
MFI also significantly decreased in RT (20.3 ± 2.66 PRE vs. 11.85 ± 1.37 POST) and there was 
a significant effect of time on MC3R MFI (FIGURE 11). MC1R MFI was not significantly 
altered in CON 16.11 ± 1.62 PRE vs. 10.68 ± 1.35 POST; FIGURE 10).  
Changes in the percentage of monocytes expressing MC1R did not significantly correlate 
with MC1R MFI, body fat percentage, body fat (g), or RMR (kcal / d) (FIGURE 12, TABLE 3). 
Changes in the percentage of monocytes expressing MC3R (POST – PRE) significantly 
correlated with changes in MC3R MFI, body fat percentage, body fat (g), and RMR (kcal / d).  































FIGURE 10. Plasma membrane expression of melancortin 1 receptor (MC1R) per 
monocyte. 
CON, active control group; RT, resistance training group. Mean fluorescent intensity (MFI) of 
MC1R expression in the RT group after the intervention (P < 0.001 by two way ANOVA). 































FIGURE 11. Melanocortin 3 receptor (MC3R) density on systemic monocytes.  
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group. The mean fluorescent density (MFI) of MC3R decreased in 
RT after the intervention and there was a significant effect of time in the model (P < 0.01 for 
treatment by two way ANOVA). *denotes significant effect of time; Ψ denotes significant effect 
of treatment  
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FIGURE 12. Correlations between the change in the percentage of monocytes expressing 
MC1R and (A) the change in MC1R receptor density, (B) change in body fat percentage, 
(C) change in body fat, and (D) change in energy expenditure. 
CON, active control group; RT, resistance trained group. 
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TABLE 3. Summary of correlations between changes in the percentage of monocytes 
expressing MCRs and changes in MC3R or MC1R plasma receptor density, changes in 
body fat percentage, changes in body fat, or changes in energy expenditure.  
CON, active control group; RT, resistance training group. MFI, mean fluorescence intensity. EE, 
energy expenditure. Values are reported as the correlation coefficient (top) and P value (bottom).  




Group  Correlation Variables  
Correlation 











Body Fat  
Change in 







protein  CON  
0.6528, 







  RT  
0.7121,  
  
0.295,  0.2946, 
0.0199*  
0.2553, 






protein  CON    





0.9787  < 0.0001*  










The largest decreases in the percentage of monocytes expressing MC3R significantly 
correlated with the smallest decreases in MC3R MFI (r
2
 = 0.7121; P < 0.0001) (FIGURE 13A). 
The largest decreases in percent body fat (r
2
 = 0.295; P < 0.05) and fat (r
2
 = 0.295; P < 0.05) 
significantly correlated with the smallest decreases in the percentage of monocytes expressing 
MC3R (FIGURES 13B and 13C). Changes in RMR (kcal / day) significantly correlated with 
changes in the percentage of monocytes expressing MC3R protein (r
2 
= 0.2553, P < 0.05;  
FIGURE 13D; TABLE 3). 
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FIGURE 13. Correlations between the change in the percentage of monocytes expressing 
melanocortin 3 receptor (MC3R) and (A) the change in MC3R receptor density, (B) change 
in body fat percentage, (C) change in body fat, and (D) change in energy expenditure. 
CON, active control group; RT, resistance trained group 
3.3.3 Plasma CRP and Cytokine Concentrations 
There were no differences in CRP between CON and EX groups at baseline.  CRP 
plasma levels did not change significantly in RT or CON individuals (FIGURE 14). However, 
CRP levels in RT decreased from a moderate risk for CVD category at the beginning of the study 
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(1.71 ± 0.59) to a low risk category Post (0.9 ± 0.26 mg/mL). Additionally, when CRP levels 
were placed in tertiles, the highest baseline tertile in the RT group experienced a significant 
decrease in CRP at the end of the 12 week intervention (2.08 ± 0.34 PRE to 1.09 ± 0.34 POST), 




















FIGURE 14. C-Reactive Protein (CRP) plasma protein levels. 
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group. There were no significant differences in CRP in either 
CON or RT groups Pre to Post. 
 
There were no differences in IL-6 or IL-10 between CON and RT groups at baseline. 
After the intervention there were no changes in IL-6 protein in RT or CON (FIGURE 15, 
TABLE 4). IL-10 protein plasma levels significantly decreased in RT, but almost the same 
degree of decrease was seen in CON individuals after the 12 week intervention (FIGURE 16, 
TABLE 4). There was also a significant effect of time on IL-10 in both CON and RT (FIGURE 
16, TABLE 4).   




FIGURE 15. Plasma interleukin-6 (IL-6) protein levels. 
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group. There were no significant differences in IL-6 in either CON 

























FIGURE 16. Interleukin-10 (IL-10) plasma protein levels. 
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group. IL-10 decreased in RT Pre vs. Post values. There was a 
significant effect of time (P < 0.0001 by two way ANOVA).  *denotes significant effect of time 
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TABLE 4. Summary of plasma protein levels of C-reactive protein (CRP), interleukin 6 
(IL-6), and interleukin 10 (IL-10). 
Pre, before the intervention period; Post, after the intervention period. CON, active control 
group; RT, resistance training group *denotes significant difference between Pre and Post values 
within CON or RT groups 
 
Variable Time  CON  RT 
CRP (total) Pre 1.42 ± 0.38 (n = 14) 1.71 ± 0.59 (n = 16) 
  Post 1.46 ± 0.41 0.9 ± 0.26 
CRP (highest tertile) Pre 3.32 ± 0.38 (n = 6) 2.08 ± 0.34 (n =9 ) 
  Post 2.56 ± 0.60 1.09 ± 0.34* 
CRP (middle Tertile) Pre 1.04 ± 0.05 (n = 5) 0.41 ± 0.03 (n = 5) 
  Post 0.98 ± 0.34 0.35 ± 0.08 
CRP (lowest tertile) Pre 0.38 ± 0.08 (n = 5) 0.24 ± 0.02 (n = 5) 
  Post 1.23 ± 0.67 0.39 ± 0.09 
IL-6 Pre 0.88 ± 0.23 (n = 19)  0.72 ± 0.10 (n = 21) 
  Post 0.97 ± 0.14 0.98 ± 0.09 
IL-10 Pre 1.32 ± 0.17 (n = 19) 1.42 ± 0.17 (n = 21) 
  Post 0.78 ± 0.10* 0.87 ± 0.13* 
 
Changes in CRP correlated with changes in body composition. Larger decreases in body 
fat percentage and body fat and larger gains in LBM directly correlated with larger decreases in 
CRP (FIGURE 17, TABLE 5). Additionally, changes in IL-6 but not IL-10 also correlated with 
changes in body composition. Larger increases in IL-6 correlated with larger decreases in body 
fat percentage and body fat and larger increases in LBM percentage (FIGURE 17, TABLE 5).  
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FIGURE 17. Correlation graphs between changes in CRP plasma protein levels and 
changes in body composition. 
Correlation graphs between changes in CRP plasma protein levels (Post – Pre) and (a) changes in 
body fat percentage (Post – Pre), (b) changes in body fat (Post – Pre), and (c) changes in lean 
body mass (LBM) percentage (Post – Pre). Also shown are correlations between changes in IL-6 
plasma levels (Post – Pre) and (d) changes in body fat percentage (Post – Pre), (e) changes in 
body fat (Post – Pre), and (f) changes in lean body mass (LBM) percentage (Post – Pre) 
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TABLE 5. Correlations between changes in plasma protein levels of C-reactive protein 
(CRP) or interleukin-6 (IL-6) and changes in body composition. 
Summary of correlations between changes in plasma protein levels of C-reactive protein (CRP) 
or interleukin-6 (IL-6) and changes in body fat percentage, changes in body fat, or changes in 
lean body mass (LBM) percentage. CON, active control group; RT, resistance training group. 
Values reported are the correlation coefficient (top), P value (bottom). * denotes significance. 
 
   Treatment Group  Correlation Variables  
Correlation 





Body Fat  
Change in 
LBM %  
Change in plasma 














Change in plasma 














Exercise is an easily manipulated and well studied form of therapy for many chornic 
diseases, such as T2D, atherosclerosis, CVD, osteoporosis and cancer. While several studies 
focus on the inflammatory pathways induced acutely after an exercise bout, here we explore the 
response of MC1R and MC3R on monocytes to repeated, chronic bouts of RT in an effort to 
propose a novel role for the melanocortin receptors in affecting anti-inflammatory exercise-
induced responses. My results are the first to show that chronic RT does affect the protein 
expression levels of MC1R and MC3R on systemic monocytes. While RT increases the number 
of cells expressing MC1R, indicating an increase in the anti-inflammatory capacity of the cells to 
stimuli, it decreases the number of cells expressing MC3R. One possible explanation for these 
conflicting results in MCR protein expression may be that the increase in MC1R may be a 
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mediating factor in the dowregulation of MC3R expression. Alternatively, exercise-induced 
decreases in MC3R cell surface expression may be compensated for by MC1R upregulation, 
allowing for the possible increase in anti-inflammatory processes within the monocyte. 
Interestingly, my data show that smaller decreases in MC3R expression per monocyte are 
significantly correlated with larger decreases in the percentage of monocytes expressing MC3R. 
Thus, the increases in the percentage of cells expressing MC1R may manifest anti-inflammatory 
effects in conjunction with the smaller decreases in MC3R expression per cell, where cells 
expressing MC1R may express less MC3R and vice versa. Although MC1R and MC3R have 
redundant immunomodulatory roles in monocytes, they may have alternate mechanisms for 
activation and translocation to the plasma membrane. For example, MC1R and MC3R bind to 
differing agonists and antagonists with differing affinities and upon stimulation with agonist, 
MC1R and MC3R may then translocate from the plasma membrane to vesicle by endoytosis, 
ultimately leading to changes in gene regulation [235-237].  
As the current study measures only cell surface expression of MC1R and MC3R, there 
may be intracellular changes in protein expression not noted here that may also help to explain 
decreases in cell surface MC3R expression. Exercise training may increase the reservoirs of 
MC3R within vesicles in the monocyte when immune cells are stimulated with pro-inflammatory 
cytokines, and are released acutely after an exercise bout, allowing for a greater induction of 
gene transcription. In this scenario, MCR agonists such as POMC or ACTH are secreted acutely 
during and after a RT bout and act either in an autocrine or paracrine manner on the monocytes. 
MC3R may then translocate to the membrane of the monocyte in an acute manner where 
activation can occur. Hence, the monocyte can respond acutely to increase MC3R cell surface 
expression and sensitize the cell to produce a faster and larger anti-inflammatory response. 
Because the change in MC3R expression may occur acutely and may be transient in nature, 
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chronic, resting plasma samples obtained at 72 hours after the last RT bout may not have 
captured the complete nature of MC3R cell surface expression. This hypothesis seems plausible 
as my previous study examining MC3R mRNA expression 24 hours after a resistance training 
bout show significantly increased MC3R in participants undergoing a 12 week RT intervention 
(unpublished data). Additional support for this hypothesis lies in the expression of MC1R and 
MC3R on individual monocytes. My data show that both MC1R and MC3R cell surface 
expression, when explored on individual monocytes, actually decreases in response to RT. Thus, 
although a greater or lesser number of monocytes express MC1R and MC3R, respectively, all 
monocytes that express each receptor possess a lower abundance of each receptor. There is a 
time-dependent decreased in MC3R plasma protein density in both RT and CON but the 
decrease in MC3R in CON showed no effect from treatment, while the decrease in MC3R 
receptor density was dependent on the treatment (RT). Thus, the time dependent decreases seen 
in MC3R may be due to seasonal variation in temperature and photoperiod, leading to 
differences in receptor expression. Indeed, several studies show that MC3R exhibits circadian 
rhythms and helps maintain circadian rhythms of several other genes in hepatocytes [238-239]. 
In addition to possible seasonal variation in MC3R, studies also show seasonal variation in IL-
10, which may also explain the decreases in IL-10 in both CON and RT as a function of time, 
although only the decreases in IL-10 were also significantly impacted by treatment (RT) [240]. It 
is also possible that seasonal changes in MC3R expression in monocytes are responsible for the 
seasonal variation seen in IL-10, as stimulation of MC3R leads upregulation and secretion of IL-
10 from monocytes [7] and MC3R expression in hepatocytes is needed to maintain circadian 
rhythms of several proteins involved in metabolism [228-229]. 
I also note that changes in MC1R and MC3R expression coincide with changes in 
systemic cytokine expression. Here, IL-6 increases, although not significantly, in response to RT 
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while IL-10 decreases. The present data is in agreement with previous studies that have noted no 
change in IL-6 at the 72 hour time point but is in disagreement with previous findings for IL-10 
which show increases or no change in IL-10 chronically in response to exercise [17, 46, 241-
242]. As my main goal in the present study was to determine chronic changes in MCR 
expression in resting plasma samples, I chose the 72 hour time point to ensure that acute changes 
in receptor expression would not confound the results. For example, Langberg et al 2002 show 
that 180 mins of running at steady pace acutely upregulates IL-6, and IL-6 levels return to 
baseline levels at 48 hours after the running bout [241].  Croisier shows that IL-6 increases 
acutely after 30 maximal eccentric contractions of the knee flexor and extensor, and these levels 
return to baseline 48 hours after the resistance training bout [46]. Hirose et al 2004 also report 
the return of IL-6 and IL-10 levels to baseline levels by 24 hours post, following 6 sets of 5 
eccentric contractions of the elbow flexors [17]. Margeli et al 2005 also show IL-6 returning to 
baseline by 48 hours after an ultradistance endurance race [243].  Conversely, others, such as 
Markovitch et al 2008 show no change in IL-6 or IL-10 during or after a bout of treadmill 
walking at an intensity of 50% VO2max [242]. It is interesting to note that MC3R and MC1R, 
both known anti-inflammatory receptors, decrease in response to RT in agreement with the 
changes in IL-10 expression, where IL-10, an anti-inflammatory cytokine, decreases. Thus, it is 
possible that the 72 hour time point may still contain the manifestations of the acute response to 
the last bout of RT training.  
Although my samples exhibit changes in MCR and cytokine expression that favor a pro-
inflammatory rather than anti-inflammatory response at the 72 hour time point, CRP tends to 
decrease (P = 0.2641) in response to RT. CRP is a much more stable marker of chronic 
inflammation than more transient cytokine levels and has recently gained acceptance in the 
medical community as a marker of CVD. Exercise has been shown to decrease CRP [38, 174-
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177]. Thus, I believe that the overall decrease in CRP in the resistance training group may be a 
consequence of the acute changes seen here. For example, changes in MCR expression may elicit 
sufficient changes in cytokines or other factors that impact CRP levels, leading to its chronic 
downregulation. Acute upregulation of pro-inflammatory cytokine, IL-6 has been shown to 
directly upregulate transcription factors, such as C/EBP, that then upregulate CRP expression. 
Others have shown that, with exercise training, downregulation of IL-6 occurs chronically 
possibly due to upregulation of IL-10 [7, 75]. In conjunction with previous reports, the lack of 
change seen in IL-6 in the current project coincides with the lack of a significant change in CRP 
levels. However, those individuals in RT expressing higher baseline levels of CRP did 
significantly decrease their CRP while no changes were seen in CON individuals expressing 
higher baseline CRP levels. Furthermore, CRP levels in RT but not CON decreased from a 
moderate risk category for CVD (1-3 mg/mL) to a low risk category for CVD (<1 mg/mL), 
indicative of decreases in chronic inflammation possibly due to acute changes in cytokines not 
represented in the present data.  
Studies have noted that changes in inflammation may be dependent on changes in 
adiposity, as increased percent fat correlates with increased inflammation [244]. Indeed, obesity 
is a disease state that is considered to be a type of low-grade chronic inflammation [245]. Here, I 
show that RT significantly decreases body fat percentage. Interestingly, changes in MC3R 
negatively correlate with changes in adiposity, where individuals losing the highest percentage of 
body fat also show the smallest decreases in the percentage of monocytes expressing MC3R. The 
role of the MC3R in the development of obesity has been studied extensively in rodent models, 
mainly in MC3R KO mice. Studies focus on the role of MC3R in the CNS, but little has been 
published on the effects of MC3R in peripheral tissues on adiposity. MC3R KO mice have been 
shown to exhibit increased adiposity despite hypophagia in comparison to wild type mice [87-88, 
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139]. Additionally, the adipose tissue of obese MC3R KO show decreased macrophage 
infiltration [87]. These previous studies indicate that peripheral MC3R expression on 
macrophages mediates macrophage activation and recruitment to sites of inflammation. Based on 
our current knowledge of the MC3R, one would expect that a decrease in adiposity and 
inflammation would correlate with increased MC3R expression on monocytes, and my data here 
supports this hypothesis. Again, I propose that while MC3R expression is decreased on the 
plasma membranes of systemic monocytes obtained from resting plasma samples, MC3R protein 
may be increased inside the monocyte where it resides in vesicles until stimulation. MC1R 
expression, on the other hand, did not correlate with changes in adiposity.  
In support of the idea that changes in inflammation are partially related to changes in 
body composition, the current study also shows that changes in body composition correlate to 
changes in circulating IL-6 and CRP protein levels but not IL-10 protein levels. Larger decreases 
in body fat percentage and body fat are directly correlated with larger decreases in CRP and 
increases in IL-6. Conversely, larger gains in LBM percentage also correlated with larger 
decreases in CRP and increases in IL-6. Because IL-6 is both a cytokine and a myokine, it is not 
surprising that IL-6 is somewhat elevated in response to increases in lean body percentage in the 
present study [181]. It is possible that the increases in acute levels of IL-6 in response to muscle  
contraction may then lead to the larger decreases in circulating levels of CRP. 
In addition to changes in MC3R correlating with changes in adiposity, MC3R was also  
negatively correlated with changes in resting metabolic rate, with participants experiencing the  
largest increases in resting metabolic rate also showing the smallest decreases in the percentage 
of monocytes expressing MC3R. These results are not surprising, as it has been discussed in 
several earlier publications that the intensity and duration of an exercise bout affects changes in 
metabolism and these changes in metabolism may lead to alterations in the inflammatory profile 
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[246]. Based on the body composition changes in the present study, the high metabolic demand 
placed on the participants as a result of our progressive, intense resistance training plan may be a 
leading cause of alterations in MC3R expression and, ultimately, monocyte activation and 
changes in cytokine production and secretion. Indeed, I did observe significant correlations 
between the changes in the number of monocytes expressing MC3R but not MC1R and changes 
in body composition. This data may further support the hypothesis that while both MC1R and 
MC3R possess similar properties such as the same agonists and downstream anti-inflammatory 
effects upon stimulation, there may be alternate mechanisms of activation and expression for 
each receptor on systemic monocytes. 
In summary, my data shows that 12 weeks of RT leads to changes in the number of 
monocytes expressing MC1R and MC3R, as well as the amount of each receptor being expressed 
on individual monocytes. To my knowledge this is the first investigation to study the expression 
of MC1R and MC3R on systemic monocytes as a novel exercise-induced anti-inflammatory 
receptor. Future studies should focus on measurement of the MCRs at various time points after a 
resistance training bout in trained and untrained individuals and correlations in MCR expression 
with cytokine expression. Exploration into the percent of intracellular versus plasma membrane  
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CHAPTER 4. GENERAL SUMMARY 
4.1 Summary 
The findings in the present study for RMR and strength gains in response to the RT plan 
are consistent with those found in other studies utilizing a young, healthy population as well as 
some diseased populations [247-249], thus I believe that the training plan was not a limitation in 
the present study. While some laboratories have reported larger increases in strength gains in 
response to resistance training than the present study, these publications did not utilize an 
acclimation period and measurement of strength was not completed using free weights and as in 
the present study; furthermore, strength assessment may have also been performed previously for 
small muscle groups. For example, Flynn et al. show that 10 wks of resistance training leads to a 
34% strength increase in leg extension and a 50% in plantar flexion in 1RM assessments [250]. 
Frontera et al show that 12 wks of resistance training in men leads to a 116.7% increase in knee 
extensor strength and 226.7% increase in knee flexor strength using 1RM assessments on a 
Cybex, a pneumatic machine [251]. Both studies, as well as most resistance training intervention 
studies, utilize a guided machine for each lift and assess strength in a more isoloated manner than 
the testing utilized in the present study. Here we used unassisted barbell bench press and squat 
for the 8RM testing which requires not only the strength to move the load but also stabilization 
of the load during the lift and muscle synergy, making it more difficult than machine assisted 
lifts. Furthermore, both the CON and RT groups in the present study underwent a 4 day 
acclimation period including the lifts used for the 8RM assessment before the intervention 
period. No acclimation period was utilized in the other aforementioned studies [250-251]. The 
acclimation period may explain the smaller changes seen in strength gains in the RT group, as it 
provided familiarization with the weight equipment as well as increased confidence in the CON 
and RT groups in the particular lifts used during the 8RM testing. Indeed, it has been shown that 
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at least 3-4 familiarization sessions with weight lifting are needed to accurately assess 1RM 
measurements in young subjects [252]. Furthermore, the present study utilized an 8RM protocol 
as a more accurate assessment of strength changes than a 1RM protocol, as the repetition range 
for a single set in the RT regimen was usually between 8-10 repetitions. The comparison of 8RM 
measurements to 1RM measurements is not a fair comparison, as derivation of an individual’s 
1RM from 8RM testing is only an estimate of the 1RM due a nonlinear association between the 
two. Although the changes in strength reported here are small to moderate, we do see large 
increases in LBM, a 1.45kg average increase, and decreases in percent fat, 1.56% decrease, in 
response to the undulating periodization utilized in the present study compared to other studies 
utilizing a progressive resistance training routine in a young, healthy population. For example, 
Poehlman et al. show that 6 months of progressive resistance training leads to no change in FM 
and a 2kg increase in LBM [253], and, in a separate study, 6 months of RT leads to no change in 
FM and a 1.3kg increase in LBM [247]. Rakobowchuk et al report a significant increase of 2.3lb 
in FM and a 3.5% increase in LBM [254]. The changes in body composition seen herein are 
indicative of an intense resistance training regimen that decreased the chance of habituation to 
the exercise stressor. In addition to determining the effects of RT in young, healthy individuals 
on RMR and strength, I set out to determine the following: 
Specific Aim 1: Determine MC1R and MC3R expression and density on plasma membranes of 
circulating monocytes in response to chronic, repeated resistance training bouts. 
Conclusion: MC1R and MC3R cell surface expression change in response to resistance training. 
The percentage of systemic monocytes expressing MC1R significantly increased in response to 
RT whereas the percentage of monocytes expressing MC1R in the CON group did not change. 
Conversely, the percentage of monocytes expressing MC3R significantly decreased in RT with 
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no change in CON. Additionally, MC1R and MC3R plasma density decreased in RT with no 
change in MC1R MFI in CON.   
Specific Aim 2: Determine if resistance training alters CRP levels in conjunction with changes 
in pro and anti-inflammatory cytokine profiles in college aged individuals.   
Conclusions: CRP levels decreased from the moderate risk category (1-3 mg/mL) to the low risk 
category (<1 mg/mL) in RT but not CON individuals, although the decrease in CRP was not 
significantly different in POST RT compared to PRE RT. However in RT, CRP levels 
significantly decreased POST in those individuals expressing higher baseline levels of CRP. RT 
participants also experienced no chane in IL-6 and significant decreases in IL-10 in conjunction 
with the changes in CRP. Concominant decreases in IL-10 were also noted in CON. Thus, 
changes in IL-10 may be due to seasonal variation rather than treatment. 
Specific Aim 3: Determine if MC1R and MC3R expression correlates to changes in the 
inflammatory profile in college-aged individuals in response to resistance training. 
Conclusions: There were no correlations between changes in MCR expression or the percentage 
of monocytes expressing MCR with changes in representative cytokine or CRP expression. 
There were, however, significant correlations between increases in the percentage of monocytes 
expressing MC3R but not MC1R and decreases in body fat percentage and increases in lean 
body mass percentage. Changes in the percentage of monocytes expressing MC3R but not 
MC1R may be dependent on changes in body composition. 
4.2 Conclusions  
MC1R did not correlate to changes in body composition or energy expenditure in RT, 
whereas changes in MC3R correlated with changes in body fat percentage, changes in body fat, 
and changes in energy expenditure. Additionally, changes in MCRs did not correlate to changes 
in cytokines. However, changes in both CRP and IL-6 correlated with changes in body fat 
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percentage, changes in body fat, and changes in lean body mass but not changes in energy 
expenditure. Changes in IL-10 did not correlate with changes in body composition or energy 
expenditure. Changes in CRP did not correlate with changes in either IL-6 or IL-10. 
Limitations 
There are several limitations to the current study worth mentioning, including the time 
point at which samples were obtained, cell surface vs. intracellular expression of MCR, 
cytokines measured, and the sample population used. For example, my previous findings show 
that resistance training increases MC3R mRNA expression 13-fold in whole blood samples in 
older overweight women. In the current study, in an effort to avoid the effects of anti-
inflammatory drug use in the older population, I proposed to examine the expression of MC3R in  
healthy, younger individuals, both men and women, with exercise training. Thus, I may not have 
observed the same changes in protein expression due to the difference in study population. 
However, I did observe a significant change in all principle outcome variables indicating that 
resistance training can influence the inflammatory profile of this population. Additionally, the 
inclusion of measurements of MC1R and MC3R mRNA or intracellular protein levels may have 
added significance to the current study, and allowed a better comparison to the findings of my 
previous study in the older postmenopausal women. I also chose the most widely measured 
cytokines in exercise science, Il-6 and IL-10, as representative cytokines for changes in pro- or 
anti-inflammatory pathways, respectively. The inclusion of additional cytokines may have added 
more significance to our finds. Also, the measurement of MCR expression at different time 
points would have allowed us to determine if the effects of the resistance training plan in the 
current study shifted the time at which systemic cytokine and MCR monocyte expression return 
to baseline levels.  
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Shoulder Press 10 1.5 
      
 
Shoulder Press 8 2 
Exercise Reps Rest 
 
      
Bench press 12 1.5 
 
Straight bar curls 10 1.5 
Bent over rows 12 1.5 
 
Straight bar curls 8 2 
Shoulder Press 10 1.5 
 
      
Straight bar curls 10 1.5 
 
Dumbell shrug 10 1.5 
Dumbell shrug 10 1.5 
 
Dumbell shrug 8 2 
Pressdowns 10 1.5 
 
      
      
 
Pressdowns 10 1.5 
Crunches 15 1 
 
Pressdowns 8 2 
Crunches 12 1 
 
      
Crunches 10   
 
Crunches 15 1 
ACC2 
 
Crunches 12 1 
      
 
Crunches 10   
Exercise Reps Rest 
 
ACC4 
Squats 15 1.5 
 
      
Deadlift 15 1.5 
 
Exercise Reps Rest 
Walking lunges 15 2 
 
Squats 15 1.5 
Extensions 12 1.5 
 
Squats 12 2 
Lying leg curls 12 1.5 
 
Deadlift 15 1.5 
      
 
Deadlift 12 2 
Standing calves 10 1.5 
 
Walking lunges 15 1.5 
Seated calves 10   
 
Walking lunges 12 2 
ACC3 
 
Extensions 15 1.5 
      
 
Extensions 12 2 
Exercise Reps Rest 
 
Lying leg curls 12 1.5 
Bench press 12 1.5 
 
Lying leg curls 10 2 
Bench press 10 2 
 
      
      
 
Standing calves 12 1.5 
Bent over rows 12 1.5 
 
Standing calves 10 2 
Bent over rows 10 2 
 
Seated calves 12 1.5 
      
 
Seated calves 10   
 
Week 3 
            
Exercise Reps Rest Exercise Reps Rest 
Bench press 12 1.5 Squats 15 1.5 
Bench press 10 1.5 Squats 12 1.5 
Bench press 8 2 Squats 10 2 
      Deadlift 10 1.5 
Bent over rows 12 1.5 Deadlift 8 1.5 
Bent over rows 10 1.5 Deadlift 6 2 
Bent over rows 8 2 Walking lunges 16 1.5 
      Walking lunges 12 1.5 
Shoulder Press 10 1.5 Walking lunges 10 2 
Shoulder Press 8 1.5 Leg extensions 18 1.5 
Shoulder Press 6 2 Leg extensions 15 1.5 
      Leg extensions 12 2 
Straight bar curls 10 1.5 Lying leg curls 12 1.5 
Straight bar curls 8 1.5 Lying leg curls 10 1.5 
Straight bar curls 6 2 Lying leg curls 8 2 
            
Dumbell shrug 10 1.5 Standing calves 12 1.5 
Dumbell shrug 8 1.5 Standing calves 10 1.5 
Dumbell shrug 6 2 Standing calves 8 2 
      Seated calves 12 1.5 
Pressdowns 10 1.5 Seated calves 10 1.5 
Pressdowns 8 1.5 Seated calves 8   
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Pressdowns 6 2 
      
Crunches 20 1 
Crunches 15 1 





                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
Bench press 10 1.5 Seated rows 10 1.5 Squats 12 1.5 
Bench press 8 1.5 Seated rows 8 1.5 Squats 10 1.5 
Bench press 6 2 Seated rows 6 2 Squats 8 1.5 
Incline press 10 1.5 Back extensions 20 1.5 Squats 6 2 
Incline press 8 1.5 Back extensions 15 1.5 Deadlifts 8 1.5 
Incline press 6 2 close grip pulldowns 12 1.5 Deadlifts 6 1.5 
inlcine push up 15 1.5 close grip pulldowns 10 2 Deadlifts 4 2 
incline push up 15 2 wide grip pulldowns 10 1.5 Walking lunges 18 1.5 
      wide grip pulldowns 8 2 Walking lunges 15 1.5 
Shoulder press 10 1.5       Walking lunges 12 2 
Shoulder press 8 1.5 Straight bar curls 10 1.5 Extensions 10 1.5 
Shoulder press 6 2 Straight bar curls 8 1.5 Extensions 8 1.5 
Lateral raises 8 1.5 Straight bar curls 6 2 Extensions 6 2 
Lateral raises 8 1.5 Hammer curls 10 1.5 Lying leg curls 10 1.5 
Lateral raises 8 2 Hammer curls 8 1.5 Lying leg curls 8 1.5 
Rear delt rows 10 1.5 Hammer curls ø 2 Lying leg curls 6 2 
Rear delt rows 8 1.5             
Rear delt rows 6 2 Crunches 25 1 Standing calves 10 1.5 
      Crunches 25 1 Standing calves 8 1.5 
Overhead DB 
extension 10 1.5 Crunches 25 2 Standing calves 6 2 
Overhead DB 
extension 8 1.5 Elbow to knee 20 1 Seated calves 30 1.5 
Overhead DB 
extension 8 2 Elbow to knee 20 1 Seated calves 25 1.5 
Pressdowns 10 1.5 Elbow to knee 20   Seated calves 20 1.5 





                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
Bench press 10 1.5 Seated rows 10 1.5 Squats 12 1.5 
Bench press 8 1.5 Seated rows 8 1.5 Squats 10 1.5 
Bench press 6 2 Seated rows 6 2 Squats 8 1.5 
Incline press 10 1.5 Back extensions 20 1.5 Squats 6 2 
Incline press 8 1.5 Back extensions 15 1.5 Deadlifts 8 1.5 
Incline press 6 2 Back extensions 12 2 Deadlifts 6 1.5 
incline push up 15 1.5 close grip pulldowns 12 1.5 Deadlifts 4 2 
incline push up 15 2 close grip pulldowns 10 2 Walking lunges 18 1.5 
      wide grip pulldowns 10 1.5 Walking lunges 15 1.5 
swimmer press 10 1.5 wide grip pulldowns 8 2 Walking lunges 12 2 
swimmer press 8 1.5       Extensions 10 1.5 
swimmer press 6 2 Straight bar curls 10 1.5 Extensions 8 1.5 
isometric DB T hold-
135 30sec 0 Straight bar curls 8 1.5 Extensions 6 2 
isometric DB T hold-
90 30sec 0 Straight bar curls 6 2 Lying leg curls 10 1.5 
isometric DB T hold-
45 30sec 1 Hammer curls 10 1.5 Lying leg curls 8 1.5 
Rear delt rows 10 1.5 Hammer curls 8 1.5 Lying leg curls 6 2 
Rear delt rows 8 1.5 Hammer curls 6 2       
Rear delt rows 6 2       Standing calves 10 1.5 
isometric DB T hold- 30sec 0 Crunches 25 1 Standing calves 8 1.5 
                                     
106 
135 
isometric DB T hold-
90 30sec 0 Crunches 25 1 Standing calves 6 2 
isometric DB T hold-
45 30sec 1 Crunches 25 2 Seated calves 30 1.5 
      Elbow to knee 20 1 Seated calves 25 1.5 
Overhead DB 
extension 10 1.5 Elbow to knee 20 1 Seated calves 20   
Overhead DB 
extension 8 1.5 Elbow to knee 20   
Overhead DB 
extension 8 2 
Pressdowns 10 1.5 






                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
medicine ball throws 30 0.5 T bar row 12 1 jump squats 20 0.5 
Dumbell press 10 1 T bar row 10 1 
side leg jump 
holds 15 0.5 
Dumbell press 8 1 T bar row 8 2 squats on plank 10 1.5 
Dumbell press 6 2 Stiff legged deadlifts 12 1 squats on plank 8 1.5 
medicine ball throws 30 0.5 Back extensions 30 1 squats on plank 6 2 
decline push ups 15 1 Close grip pulldowns 12 1 jump squats 20 0.5 
decline push ups 12 2 Close grip pulldowns 10 2 
side leg jump 
holds 15 0.5 
Cable crossovers 12 1 Close grip pulldowns 8 2 side step squats 10 1.5 
Cable crossovers 10 2 Stiff legged deadlifts 10 1 side step squats 8 1.5 
      Back extensions 25 1 side step squats 6 2 
Close grip bench press 10 1       jump squats 20 0.5 
Close grip bench press 8 1 Dumbell curls 10 1 
side leg jump 
holds 15 0.5 
Close grip bench press 6 2 Dumbell curls 8 1 step ups 12 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine 
ball toss 25 0.5 2 box jump 15 0.5 
Lying tricep extension 10 1 incline dumbell curl 10 1 cross the river 10 0.5 
Lying tricep extension 10 1 incline dumbell curl 8 2 step ups 10 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine 
ball toss 25 0.5 2 box jump 15 0.5 
      Concentration curls 12 1.5 cross the river 10 0.5 
swimmer press 10 1.5 Concentration curls 12 2 step ups 8 1.5 
swimmer press 8 1.5             
swimmer press 6 2 Butterfly crunches 40 1 
one legged 
standing calves 30 1 
isometric DB T hold-135 30sec 0 Butterfly crunches 30 1 
one legged 
standing calves 30 1 
isometric DB T hold-90 30sec 0 Butterfly crunches 30 1.5 
one legged 
standing calves 25 1 
isometric DB T hold-45 30sec 1 medicine ball twist 30 1 
one legged 
standing calves 50 2 
front raises 10 1.5 medicine ball twist 25 1 seated calve raises 30 1 
front raises 8 1.5 medicine ball twist 20   seated calve raises 30 1 
front raises 6 2 scissors 40 1 seated calve raises 25 1 
isometric DB T hold-135 30sec 0 scissors 30 1 seated calve raises 50 2 
isometric DB T hold-90 30sec 0 scissors 30 1.5 





                  
Exercise 
Rep
s Rest Exercise Reps Rest Exercise Reps Rest 
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medicine ball throws 30 0.5 T bar row 12 1 jump squats 20 0.5 
Dumbell press 10 1 T bar row 10 1 
side leg jump 
holds 15 0.5 
Dumbell press 8 1 T bar row 8 2 squats on plank 10 1.5 
Dumbell press 6 2 Stiff legged deadlifts 12 1 squats on plank 8 1.5 
medicine ball throws 30 0.5 Back extensions 30 1 squats on plank 6 2 
decline push ups 15 1 Close grip pulldowns 12 1 jump squats 20 0.5 
decline push ups 12 2 Close grip pulldowns 10 2 
side leg jump 
holds 15 0.5 
Cable crossovers 12 1 Close grip pulldowns 8 2 side step squats 10 1.5 
Cable crossovers 10 2 Stiff legged deadlifts 10 1 side step squats 8 1.5 
      Back extensions 25 1 side step squats 6 2 
Close grip bench press 10 1       jump squats 20 0.5 
Close grip bench press 8 1 Dumbell curls 10 1 
side leg jump 
holds 15 0.5 
Close grip bench press 6 2 Dumbell curls 8 1 step ups 12 1.5 
overhead medicine ball tosses 25 0.5 
underhand medicine 
ball toss 25 0.5 2 box jump 15 0.5 
Lying tricep extension 10 1 incline dumbell curl 10 1 cross the river 10 0.5 
Lying tricep extension 10 1 incline dumbell curl 8 2 step ups 10 1.5 
Lying tricep extension 8 2 
underhand medicine 
ball toss 25 0.5 2 box jump 15 0.5 
      Concentration curls 12 1.5 cross the river 10 0.5 
Front raises 12 1 Concentration curls 12 2 step ups 8 1.5 
Front raises 10 1             
Front raises 8 2 Butterfly crunches 40 1 
one legged 
standing calves 30 1 
Upright rows 10 1 Butterfly crunches 30 1 
one legged 
standing calves 30 1 
Upright rows 8 2 Butterfly crunches 30 1.5 
one legged 
standing calves 25 1 
rear delt cable pulls 12 1 medicine ball twist 30 1 
one legged 
standing calves 50 2 
rear delt cable pulls 10 1 medicine ball twist 25 1 seated calve raises 30 1 
rear delt cable pulls 8 2 medicine ball twist 20   seated calve raises 30 1 
scissors 40 1 seated calve raises 25 1 
scissors 30 1 seated calve raises 50 2 




                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
push ups 20 0 Curl and Press 12 0 Squats 30 0 
lawnmowers 12 0 pushdowns 12 0 walking toe lunges 20 0 
                  
military push ups 15 0 Straight bar curls 12 0 run stance squats 30 0 
wide grip pulldowns 12 0 switch grip kickbacks 12 0 step ups 25 0.5 
      lateral raises 10 0       
decline push ups 20 0       Squats 30 0 
underhand pulldowns 12 0 hold and curl 12 0 walking toe lunges 20 0 
      skull crushers 10 0       
side step pushups 18 0 upright rows 12 0 run stance squats 30 0 
close grip pulldowns 10 0       step ups 25 0.5 
      pronating curls 10 0       
triangle pushups 16 0 skull crushers 10 0 wall squat 1min 0.1 
seated rows 8 0 upright rows 12 0.5 
one legged floor 
touches 25 0 
                  
push ups 20 0 hold and curl 10 0 
one legged wall 
squat 1min 1.5 
lawnmowers 10 0.5 standing kickbacks 10 0 lunge and kick 15 0 
      
seated straight and leaning 
shoulder flyes 12 0       
military push ups 15 0       wall squats 1min 0.1 
wide grip pulldowns 15 0.5 Curl and Press 12 0 one legged floor 25 0.5 
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touches 
      pushdowns 12 0       
decline push ups 20 0       
one legged wall 
squat 1min 1.5 
underhand pulldowns 12 0.5 Straight bar curls 12 0 lunge and kick 15 0 
      switch grip kickbacks 12 0       
side step pushups 18 0 lateral raises 10 0 wall squat 1min 0.1 
close grip pulldowns 10 0.5       
one legged floor 
touches 25 0.5 
      pronating curls 10 0       
triangle pushups 16 0 standing kickbacks 10 0 holds 1min 0 
seated rows 8 0.5 
seated straight and leaning 
shoulder flyes 12 0 holds 1min 0 
      holds 30sec 0 
holds 1min 0 frog 30 0 
holds 1min 0 one leg holds 1min 0 
holds 30sec 0 one leg holds 1min 0 
frog 30 0 scissors 30 0 
one leg holds 1min 0 
reach and cross toe 
touch 50 0 
one leg holds 1min 0 fist twists 50 0 
scissors 30 0 
reach and cross toe touch 50 0 





                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
medicine ball throws 30 0.5 T bar row 12 1 jump squats 20 0.5 
Dumbell press 10 1 T bar row 10 1 side leg jump holds 15 0.5 
Dumbell press 8 1 T bar row 8 2 squats on plank 10 1.5 
Dumbell press 6 2 Stiff legged deadlifts 12 1 squats on plank 8 1.5 
medicine ball throws 30 0.5 Back extensions 30 1 squats on plank 6 2 
decline push ups 15 1 Close grip pulldowns 12 1 jump squats 20 0.5 
decline push ups 12 2 Close grip pulldowns 10 2 side leg jump holds 15 0.5 
Cable crossovers 12 1 Close grip pulldowns 8 2 side step squats 10 1.5 
Cable crossovers 10 2 Stiff legged deadlifts 10 1 side step squats 8 1.5 
      Back extensions 25 1 side step squats 6 2 
Close grip bench press 10 1       jump squats 20 0.5 
Close grip bench press 8 1 Dumbell curls 10 1 side leg jump holds 15 0.5 
Close grip bench press 6 2 Dumbell curls 8 1 step ups 12 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine ball 
toss 25 0.5 2 box jump 15 0.5 
Lying tricep extension 10 1 incline dumbell curl 10 1 cross the river 10 0.5 
Lying tricep extension 10 1 incline dumbell curl 8 2 step ups 10 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine ball 
toss 25 0.5 2 box jump 15 0.5 
      Concentration curls 12 1.5 cross the river 10 0.5 
swimmer press 10 1.5 Concentration curls 12 2 step ups 8 1.5 
swimmer press 8 1.5             
swimmer press 6 2 Butterfly crunches 40 1 
one legged standing 
calves 30 1 
isometric DB T hold-135 30sec 0 Butterfly crunches 30 1 
one legged standing 
calves 30 1 
isometric DB T hold-90 30sec 0 Butterfly crunches 30 1.5 
one legged standing 
calves 25 1 
isometric DB T hold-45 30sec 1 medicine ball twist 30 1 
one legged standing 
calves 50 2 
front raises 10 1.5 medicine ball twist 25 1 seated calve raises 30 1 
front raises 8 1.5 medicine ball twist 20   seated calve raises 30 1 
front raises 6 2 scissors 40 1 seated calve raises 25 1 
isometric DB T hold-135 30sec 0 scissors 30 1 seated calve raises 50   
isometric DB T hold-90 30sec 0 scissors 30   
isometric DB T hold-45 30sec   





                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
medicine ball throws 30 0.5 T bar row 12 1 jump squats 20 0.5 
Dumbell press 10 1 T bar row 10 1 side leg jump holds 15 0.5 
Dumbell press 8 1 T bar row 8 2 squats on plank 10 1.5 
Dumbell press 6 2 Stiff legged deadlifts 12 1 squats on plank 8 1.5 
medicine ball throws 30 0.5 Back extensions 30 1 squats on plank 6 2 
decline push ups 15 1 Close grip pulldowns 12 1 jump squats 20 0.5 
decline push ups 12 2 Close grip pulldowns 10 2 side leg jump holds 15 0.5 
Cable crossovers 12 1 Close grip pulldowns 8 2 side step squats 10 1.5 
Cable crossovers 10 2 Stiff legged deadlifts 10 1 side step squats 8 1.5 
      Back extensions 25 1 side step squats 6 2 
Close grip bench press 10 1       jump squats 20 0.5 
Close grip bench press 8 1 Dumbell curls 10 1 side leg jump holds 15 0.5 
Close grip bench press 6 2 Dumbell curls 8 1 step ups 12 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine ball 
toss 25 0.5 2 box jump 15 0.5 
Lying tricep extension 10 1 incline dumbell curl 10 1 cross the river 10 0.5 
Lying tricep extension 10 1 incline dumbell curl 8 2 step ups 10 1.5 
overhead medicine ball 
tosses 25 0.5 
underhand medicine ball 
toss 25 0.5 2 box jump 15 0.5 
      Concentration curls 12 1.5 cross the river 10 0.5 
swimmer press 10 1.5 Concentration curls 12 2 step ups 8 1.5 
swimmer press 8 1.5             
swimmer press 6 2 Butterfly crunches 40 1 
one legged standing 
calves 30 1 
isometric DB T hold-135 30sec 0 Butterfly crunches 30 1 
one legged standing 
calves 30 1 
isometric DB T hold-90 30sec 0 Butterfly crunches 30 1.5 
one legged standing 
calves 25 1 
isometric DB T hold-45 30sec 1 medicine ball twist 30 1 
one legged standing 
calves 50 2 
front raises 10 1.5 medicine ball twist 25 1 seated calve raises 30 1 
front raises 8 1.5 medicine ball twist 20   seated calve raises 30 1 
front raises 6 2 scissors 40 1 seated calve raises 25 1 
isometric DB T hold-135 30sec 0 scissors 30 1 seated calve raises 50   
isometric DB T hold-90 30sec 0 scissors 30   




                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
Close grip bench press 10 1 Squats 15 1.5 bench press 8 1 
Close grip bench press 10 1 Squats 8 2 bench press 8 2 
Close grip bench press 10 2 Squats 6 2 bench press 6 2 
standing switch grip kickbacks 14 1 Squats 4 2 bench press 6 2 
standing switch grip kickbacks 14 2 Squats 2 2 incline press 6 1 
wide rope pushdowns 8 1 Extensions 8 1.5 incline press 6 2 
wide rope pushdowns 8 2 Extensions 8 2 flyes 8 1 
      Lying leg curls 8 1.5 flyes 8 2 
reverse cable dumbell curls 8 1 Lying leg curls 8 2       
reverse cable dumbell curls 8 2       seated rows 12 1 
incline dumbell curl 8 1 Standing calves 8 1.5 seated rows 12 1 
incline dumbell curl 8 2 Standing calves 6 2 seated rows 10 1 
pronating curls 8 1 Seated calves 30 1.5 Stiff legged deadlifts 15 1 
pronating curls 8 2 Seated calves 25 1.5 Stiff legged deadlifts 12 1 
      Seated calves 20   switch grip pulldowns 10 1 
pullovers 8 1 switch grip pulldowns 10 1 
pullovers 8 1 switch grip pulldowns 10   
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military press 10 1 
military press 10 2 
reverse pullovers 8 1 
reverse pullovers 8 2 
      
plank 40 0.5 
plank 30 0.5 
plank 30 1 
medicine ball twist 30 0.5 
medicine ball twist 25 0.5 
medicine ball twist 20 1 
leg press ups 40 0.5 
leg press ups 30 0.5 




                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
seated calve raises 30 1 bench press 15 1 Close grip bench press 10 1 
seated calve raises 30 1 bench press 8 2 Close grip bench press 10 1 
seated calve raises 25 0.5 bench press 6 2 Close grip bench press 10 2 
seated calve raises 50   bench press 4 2 standing switch grip kickbacks 14 1 
Lying leg curls 10 1.5 bench press 2 2 standing switch grip kickbacks 14 2 
Lying leg curls 10 1.5 incline press 6 1 wide rope pushdowns 8 1 
Lying leg curls 10 1.5 incline press 6 2 wide rope pushdowns 8 2 
mary catherine lunges 15 2 flyes 8 1       
Extensions 10 1.5 flyes 8 2 reverse cable dumbell curls 8 1 
Extensions 10 1.5       reverse cable dumbell curls 8 2 
Extensions 10 1.5 seated rows 12 1 incline dumbell curl 8 1 
mary catherine lunges 15 2 seated rows 10 1 incline dumbell curl 8 2 
Squats 8 1.5 Stiff legged deadlifts 15 1 pronating curls 8 1 
Squats 8 1.5 Stiff legged deadlifts 12 1 pronating curls 8 2 
Squats 8 1.5 switch grip pulldowns 10 1       
mary catherine lunges 15 2 switch grip pulldowns 10   pullovers 8 1 
Deadlifts 8 1.5 pullovers 8 1 
Deadlifts 8 1.5 military press 10 1 
mary catherine lunges 15   military press 10 2 
reverse pullovers 8 1 
reverse pullovers 8 2 
      
plank 40 0.5 
plank 30 0.5 
plank 30 1 
medicine ball twist 30 0.5 
medicine ball twist 25 0.5 
medicine ball twist 20 1 
leg press ups 40 0.5 
leg press ups 30 0.5 





                  
Exercise Reps Rest Exercise Reps Rest Exercise Reps Rest 
deadlifts 15 1 holds 1min 0 seated calve raises 30 1 
deadlifts 8 2 holds 1min 0 seated calve raises 30 1 
deadlifts 6 2 holds 30sec 0 seated calve raises 25 0.5 
deadlifts 4 2 frog 30 0 seated calve raises 50   
deadlifts 2 2 one leg holds 1min 0       
deadlifts 2 2 one leg holds 1min 0 Lying leg curls 10 1 
switch grip pulldowns 10 1 scissors 30 0 Lying leg curls 10 2 
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switch grip pulldowns 10 2 reach and cross toe touch 50 0 3 angle lunge and kick  30 0 
      fist twists 50 0 mary catherine lunges 15 0 
bench press 8 1       Extensions 10 1 
bench press 8 2 standing switch grip kickbacks 14 1 Extensions 10 2 
bench press 6 2 standing switch grip kickbacks 14 2 3 angle lunge and kick  30 0 
bench press 6 2 wide rope pushdowns 8 1 mary catherine lunges 15 0 
decline push ups 6 1 wide rope pushdowns 8 2 Squats 8 1.5 
decline push ups 6 2       Squats 8 1.5 
flyes 8 1 reverse cable dumbell curls 8 1 Squats 8 2 
flyes 8 2 reverse cable dumbell curls 8 2 3 angle lunge and kick  30 0 
pronating curls 8 1 mary catherine lunges 15 0 
pronating curls 8 2 Deadlifts 8 1.5 
      Deadlifts 8   
pullovers 8 1 
pullovers 8 1 
military press 10 1 
military press 10 2 
reverse pullovers 8 1 
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APPENDIX 2. PARTICIPANT CONSENT FORM 
1. Study Title:  Strength Training Induced Alterations in Markers of  
                           Immune Function  
 
2.  Performance Site:  Louisiana State University 
                               Baton Rouge, LA 70803 
3.  Investigators:  The following investigators are available for questions about this study,   
 M-F, 8:00 a.m.- 10:40 a.m., 1:40 p.m. - 4:30 p.m. 
Principal Investigator:  Laura K. Stewart, Ph.D. 
Co-investigator:  Tara Henagan, 
4.  Purpose of the Study: 
The purpose of this research project is to examine the effect of a 12 week 
intensive strength training intervention on markers of immunity. 
Subject Inclusion:   
Participants in both the control and training groups must be at least 18 years of 
age and currently enrolled as students at LSU and may not be pregnant.  Students 
in the training group must have medical clearance following a complete 
comprehensive physical from a State licensed M.D. or D.O. The cleared student 
must provide documentation of permission by returning a signed “Physician 
Approval Form” after the physical and before participating in the study.  Students 
must complete a physical activity readiness questionnaire (PAR-Q) before 
participating.   
5. Number of subjects = 60 (n = 30 in the training group and n = 30 in the control group).   
6. Study Procedures:   
Baseline:  Before the 12 week training program begins, you will have baseline 
measurements taken.  This will include height, weight, blood pressure, heart rate, 
body composition (body fat percentage, bone mineral density) taken with a DXA 
and skinfold measurements taken with a Lange skinfold caliper.  At this time, you 
will also fill out questionnaires. We will take a resting/fasting venous blood 
sample from your antecubital vein between 6 and 9am. An assessment of your 
physical fitness will be estimated by having you perform a  8RM test with blood 
lactate measurements taken by finger prick every 5 minutes up to 30 minutes after 
your resistance training bout.  
12 Week Intervention Program:  At the start of the program, you will be provided with a 
suggested training program (training groups only). If you choose not to follow 
this training program, you will not be penalized. Throughout the 12 week training 
period, all groups will fill out a training log and a 3-day diet recall log, as well as 
a sickness and injury inventory questionnaire. This should take about 20 minutes 
weekly to complete.  Participants in the control group will be instructed to 
continue ususal day to day activities.  Participants in both groups will continue to 
complete weekly training and diet logs, and sickness inventory questionnaires. 
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Post-Training:  During the last week of class, you will undergo post-training measures. 
Procedures for post-training measurements will be identical to the protocol 
followed for preliminary measures. 
7. Benefits:   
While no guarantee of benefits can be made, you will be given training instruction 
and a body composition analysis at no cost to you.  You may also learn more 
about your physical capacity for strength and should significantly improve your 
anaerobic fitness. Subjects will be provided a comparison of his/her pre-training 
and post-training results at the end of the semester. 
8. Risks/Discomforts: 
Exercise Training & Testing:  As with any exercise program, there is a chance 
that you will experience muscle soreness, fatigue, or even injuries such as sprains 
or strains. There is also a remote risk of a heart attack or stroke and in very rare 
cases, death. Precautions to minimize this risk have been taken by requiring 
medical clearance to participate as well as completion of a health history 
questionnaire.  Your cooperation in obtaining approval from your physician as 
well as providing honest answers in completing the health history form will 
decrease this risk.   
DXA:  The Dual Energy X-Ray Absorptiometry test uses an x-ray technique to 
assess the density of your body and can then provide an accurate estimate of body 
fat percentage and lean body mass.  The whole body DXA scan exposes subjects 
to low levels of ionizing radiation. No discomfort will be felt during the DXA 
scan. There is a risk of radiation exposure from this test, but it is well below the 
level that would provide any adverse effects.  The total body DXA Scan will 
produce less than 0.37 µSV (0.037 mrem) of ionizing radiation skin entrance 
dosage. The skin entrance dose of 0.37 µSV is well below the yearly public limit 
dose for incidental exposure of 1,000 µSV (100 mrems). 
Skinfold measurements: Since a slight pinching of the skin is required to measure 
subcutaneous fat through calipers, you may experience mild bruising in the 
measurement sites (chest, midaxillary, triceps, subscapular, abdomen, suprailiac, 
and thigh). 
Blood Sampling:  There is a risk of bruising and a remote risk of infection with 
the blood sampling techniques.  You may also become lightheaded and faint 
during these procedures.  These risks will be minimized by having trained 
technicians using sterile, single-use supplies for blood sampling.  You will be 
seated during blood sampling, but you should tell us if you feel dizzy or faint. 
In addition to the risks listed above, you may experience a previously unknown risk or 
side effect. 
9.  Injury/Illness:   
 
In the unlikely event of injury or medical illness resulting from the above 
procedures, contact Laura Stewart, Ph.D., 225-578-3549. You will be referred 
for treatment, but the expense of medical treatment will be your responsibility. No 
compensation is available in case of study-related illness or injury.  
 
10. Right to Refuse:  
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You may choose not to participate or to withdraw from the study at any     
       time without penalty or loss of any benefit to which you might otherwise be 
entitled. 
 
11. Privacy:   
Your identity will remain confidential unless disclosure is required by law.  In 
other words, data will be kept confidential unless release is legally compelled.  
All data collected will be handled only by the investigators and kept in a secure 
location.  Results of the study may be published using group means only and 
names or identifying information will not be included in the publication. 
12. Financial Information:   
There is no cost to you, nor is there any compensation for participating in the 
study. 
13. Signatures:   
The study has been discussed with me and all my questions have been  answered.  
I may direct additional questions regarding study specifics to the investigators.  
If I have any questions about subjects’ rights or other concerns, I can contact 
Robert C. Matthews, Institutional Review Board at (225) 578-8692.  I agree to 
participate in the study described above and acknowledge the investigator’s 
obligation to provide me with a signed copy of this consent form. 
 
 
_____________________ ______________         
      Participant’s Signature            Date 
The study subject has indicated that s/he is unable to read.  I certify that I have read this consent 
form to the subject and explained that by completing the signature line above, the subject has 
agreed to participate.   
 
 
_____________________ ______________         
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APPENDIX 3. IPAQ 
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APPENDIX 4. PHYSICIAN’S APPROVAL FORM 
Physician Approval Form 
Kinesiology 4501 
The Physiology of Endurance Training 
*This physical must be completed by a State licensed M.D. or D.O. only* 
 
 
 I have completed a full comprehensive physical examination of _____________________ (print 
student’s full name) as required for him/her to participate in Kinesiology 4501 (The Physiology 
of Weight Training).  I understand that the student will be engaging in an intensive resistance 
training and conditioning program which will involve optional participation in a course-
designated weight lifting routine for the Spring 2010 semester. Based on my physical findings, I 
am making the following recommendation related to the demands of the course: 
 
____ Patient is cleared to participate without restriction. 
____ Patient is cleared to participate with the following restrictions or guidelines.  
__________________________________________________________________ 
_____ Patient is not cleared to participate. 
 
Physician Signature: _________________________________________________ 
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VITA 
Tara M. Henagan was born to Margaret Edana Henagan and Charles Rory Henagan in 
Baton Rouge, Louisiana. After several moves as a child, Tara became a permanent resident of 
Louisiana at the age of ten and attended St. Louis King of France School until the eighth grade. 
Tara graduated from St. Michael the Archangel High School in 2000. She attended Louisiana 
State University with a Honors TOPS scholarship and graduated with a Bachelor of Science 
degree in biological sciences with a minor in anthropology in 2004.  
Upon completion of her degree program in 2004, Tara worked as a Research Assistant in 
Dr. Thomas W. Gettys’ laboratory at the Pennington Biomedical Research Center, where her 
appreciation of science and scientific research blossomed. While working with Dr. Gettys, Tara 
met a fellow researcher and postdoctoral fellow, Dr. Laura K. Stewart. Due to their mutual 
regard for scientific research, Tara followed in Dr. Stewart’s footsteps and entered the graduate 
program with Dr. Stewart as her mentor in 2007. While in graduate school, Tara received the 
Corbett Graduate Student Summer Fellowship and a recurring teaching assistantship in the 
School of Education through the Department of Kinesiology. In 2010, Tara passed her Certified 
Strength and Conditioning examination. She plans to utilize her knowledge in weight lifting to 
help others achieve a healthier lifestyle. Tara plans to graduate from the graduate program at 
LSU in December 2010, only three short years after joining the program, with a Doctor of 
Philosophy in kinesiology and a minor in pathobiological sciences. 
